{"text": "Overall , fewer than 1.9 % of all the patients required and received vitamin A or E supplementation .Almost all patients who needed vitamin supplementation achieved normal levels by the end of the study .", "label": "", "metadata": {}, "score": "27.41631"}
{"text": "However , the studies were all non - comparative trials .In contrast , randomized controlled trials have reported negative results when vitamin C was administered orally [ 14 - 18 ] .", "label": "", "metadata": {}, "score": "30.42018"}
{"text": "The usefulness of the Vitamin E Delta - tocotrienol in treating human tumors is unknown .Adverse events will be recorded throughout the study .Study Type ICMJE .", "label": "", "metadata": {}, "score": "36.719185"}
{"text": "The effect of vitamin C injection was evident in subjects with an initially lower vitamin C level and not in subjects with initially higher levels .", "label": "", "metadata": {}, "score": "36.841972"}
{"text": "A Phase I Dose - Escalation Study of the Safety , Pharmacokinetics , and Pharmacodynamics of Vitamin E \u03b4 - Tocotrienol Administered to Subjects With Resectable Pancreatic Exocrine Neoplasia .", "label": "", "metadata": {}, "score": "36.951324"}
{"text": "We suggest that vitamin C is especially effective in subjects with relatively low baseline levels of vitamin C. Therefore , inconsistent results of previous studies ( 12 , 13 , 14 - 18 ) may result from route of administration , baseline vitamin C levels of subjects , or both .", "label": "", "metadata": {}, "score": "38.504295"}
{"text": "Vitamin C pharmacokinetics in healthy volunteers : evidence for a recommended dietary allowance .Proc Natl Acad Sci USA 1996 , 93 ( 8) : 3704 - 3709 .", "label": "", "metadata": {}, "score": "38.59887"}
{"text": "Further study is required to determine effective dose ranges of vitamin C for treatment of fatigue , and serial measurements of fatigue should clarify effective dosage windows .", "label": "", "metadata": {}, "score": "39.165077"}
{"text": "As secondary end - points , oxidative stress levels were compared between the two groups using ANCOVA with similar adjustment of baseline levels .Using independent t - tests , plasma vitamin C concentrations were compared between the two groups at baseline and two hours after intervention , respectively .", "label": "", "metadata": {}, "score": "39.273586"}
{"text": "Since there have been few randomized controlled studies evaluating the efficacy of intravenous vitamin C [ 10 ] , we sought to reevaluate the effects of intravenous vitamin C. The purpose of this study was to determine the efficacy of high dose vitamin C injection on fatigue in healthy workers , in a randomized controlled trial .", "label": "", "metadata": {}, "score": "39.531616"}
{"text": "Our subgroup analysis on the effects on the \" fatigue right now \" scores indicate that vitamin C injection efficacy is affected by baseline vitamin C levels .", "label": "", "metadata": {}, "score": "40.24147"}
{"text": "[ Time Frame : 12 weeks per participant ] [ Designated as safety issue : Yes ] .Determine the bioavailability of Vitamin E \u03b4 - Tocotrienol in normal and neoplastic pancreatic tissue .", "label": "", "metadata": {}, "score": "40.562088"}
{"text": "There were no significant differences among outcomes assessed two hours after intervention and one day after intervention ( data not shown ) .We conclude that fatigue was significantly improved two hours after vitamin C injection and that the effect persisted one day after the intervention ( Figure 2 ) .", "label": "", "metadata": {}, "score": "41.03385"}
{"text": "We have shown that administration of high dose intravenous vitamin C reduced fatigue significantly compared to placebo in office workers .Moreover , the effect of intervention was strongest in subjects with lower baseline levels of vitamin C and , interestingly , the effect lasted until the next day .", "label": "", "metadata": {}, "score": "41.077682"}
{"text": "Intravenous administration of vitamin C bypasses the controls described above , and results in high plasma concentrations .Although we did not use a depletion - repletion study design , we measured plasma levels of vitamin C of 267.90 \u00b1 141.83 \u03bcg / ml ( mean \u00b1 SD ) two hours after intervention .", "label": "", "metadata": {}, "score": "41.76133"}
{"text": "View Article .Connolly DA , Lauzon C , Agnew J , Dunn M , Reed B : The effects of vitamin C supplementation on symptoms of delayed onset muscle soreness .", "label": "", "metadata": {}, "score": "41.8973"}
{"text": "Previous studies of vitamin C treatment for fatigue have led to disparate results : in some studies , treatment with vitamin C improved fatigue significantly [ 12 , 13 ] ; in others , the treatment proved ineffective [ 14 - 18 ] .", "label": "", "metadata": {}, "score": "42.53261"}
{"text": "Vitamin D3 was well tolerated ; there were no supplement - related serious adverse clinical events or hypercalcemia .Further research is required to establish the safety of high - dose vitamin D3 in pregnancy and to determine if supplement - induced [ 25(OH)D ] elevations lead to maternal - infant health benefits .", "label": "", "metadata": {}, "score": "42.68502"}
{"text": "[ Time Frame : 12 weeks per participant ] [ Designated as safety issue : Yes ] .To characterize the safety and tolerability of Vitamin E \u03b4 - Tocotrienol when orally administered at up to 5.6 times the predicted biological effective dose ( 1600 mg twice daily ) for 14 ( \u00b1 2 ) consecutive days and one dose the day of surgery in patients with pancreatic neoplasia .", "label": "", "metadata": {}, "score": "43.024826"}
{"text": "Vitamin C is a well - known antioxidant .Several studies have shown that vitamin C can have clinical value in its role as an antioxidant .", "label": "", "metadata": {}, "score": "43.65759"}
{"text": "Nevertheless , studies of the efficacy of vitamin C supplementation have yielded inconsistent results .Route of administration is one of the major sources of inconsistency .", "label": "", "metadata": {}, "score": "44.017845"}
{"text": "Antioxidant Capacity of Intravenous Vitamin C .We have observed in our clinic that some patients with fatigue benefit from vitamin C while others do not ; therefore , we tried to find the characteristics of the responsive group .", "label": "", "metadata": {}, "score": "44.232483"}
{"text": "View Article .Thompson D , Williams C , McGregor SJ , Nicholas CW , McArdle F , Jackson MJ , Powell JR : Prolonged vitamin C supplementation and recovery from demanding exercise .", "label": "", "metadata": {}, "score": "44.81076"}
{"text": "The 50 th percentile of the baseline vitamin C level was 10.97 \u03bcg / ml in the trial group and 11.88 \u03bcg / ml in the placebo group .", "label": "", "metadata": {}, "score": "45.103653"}
{"text": "Cederberg J , Siman CM , Eriksson UJ : Combined treatment with vitamin E and vitamin C decreases oxidative stress and improves fetal outcome in experimental diabetic pregnancy .", "label": "", "metadata": {}, "score": "45.107136"}
{"text": "First , fatigue measurements were acquired only three times , and plasma vitamin C measurements were made only two times .The association between vitamin C administration and fatigue would have been clearer if we had included more data points in the study .", "label": "", "metadata": {}, "score": "45.720787"}
{"text": "Since vitamin C is a well - known antioxidant , oxidative stress was measured .Fatigue score , oxidative stress , and plasma vitamin C levels were measured before intervention , and again two hours and one day after intervention .", "label": "", "metadata": {}, "score": "45.92579"}
{"text": "Vitamin D polymorphism ( rs4646536 ) and VEGF polymorphisms ( rs699947 and rs1570360 ) were assessed using the ABI TaqMan allelic discrimination kit by real - time PCR with standard methodology .", "label": "", "metadata": {}, "score": "46.41645"}
{"text": "Results .Conclusion .Thus , intravenous vitamin C reduced fatigue at two hours , and the effect persisted for one day .There were no significant differences in adverse events between two groups .", "label": "", "metadata": {}, "score": "46.813103"}
{"text": "Background .Studies of the efficacy of vitamin C treatment for fatigue have yielded inconsistent results .One of the reasons for this inconsistency could be the difference in delivery routes .", "label": "", "metadata": {}, "score": "47.057953"}
{"text": "Serum vitamin D baseline values were available for 36 patients and circulating vitamin D polymorphism for 28 patients .Vitamin D polymorphism failed to be associated with hypertension , proteinuria , and PFS ( data not shown ) .", "label": "", "metadata": {}, "score": "47.345047"}
{"text": "Nutrition 2007 , 23 ( 5 ) : 419 - 423 .View Article .Close GL , Ashton T , Cable T , Doran D , Holloway C , McArdle F , MacLaren DP : Ascorbic acid supplementation does not attenuate post - exercise muscle soreness following muscle - damaging exercise but may delay the recovery process .", "label": "", "metadata": {}, "score": "47.661728"}
{"text": "View Article .Bryer SC , Goldfarb AH : Effect of high dose vitamin C supplementation on muscle soreness , damage , function , and oxidative stress to eccentric exercise .", "label": "", "metadata": {}, "score": "47.720222"}
{"text": "Two consecutive low vitamin E and -carotene values occurred more frequently in patients treated with orlistat compared with those given placebo , while the frequency of 2 consecutive low vitamin A and D values was not significantly different among treatment groups ( Table 6 ) .", "label": "", "metadata": {}, "score": "48.05632"}
{"text": "Although association does not mean causality , this finding suggests that bevacizumab - induced proteinuria can be effectively treated with adequate vitamin D supplementation .Strong support for this hypothesis comes from a multicenter prospective randomized clinical trial which showed that paricalcitol administered to patients with diabetic nephropathy can lower albuminuria [ 26 ] .", "label": "", "metadata": {}, "score": "48.26187"}
{"text": "While this difference may seem small in the present trial , the 120-mg dosage was significantly more effective in other trials , which were statistically powered to test for the difference between dosages .", "label": "", "metadata": {}, "score": "48.591454"}
{"text": "Methods .We evaluated the effect of intravenous vitamin C on fatigue in office workers .A group of 141 healthy volunteers , aged 20 to 49 years participated in this randomized , double - blind , controlled clinical trial .", "label": "", "metadata": {}, "score": "48.66052"}
{"text": "It was designed to demonstrate a clear relationship between the rPA102 dose administered and the subsequent immune response .Safety data were positive with no serious adverse events or toxicities reported .", "label": "", "metadata": {}, "score": "48.89971"}
{"text": "In a Korean study , vitamin C injection ( 10 g twice a week ) improved fatigue in inpatients with terminal cancer [ 13 ] .", "label": "", "metadata": {}, "score": "48.936554"}
{"text": "The present study approximates these conditions ; that is , use of an antiobesity medication without intensive dietary and behavioral counseling while still maintaining an acceptable standard of care .", "label": "", "metadata": {}, "score": "49.120766"}
{"text": "In predefined ancillary studies we also explored the role of circulating VEGF , VEGF polymorphisms , vitamin D status , and vitamin D metabolism - related polymorphism in predicting toxicities and treatment efficacy .", "label": "", "metadata": {}, "score": "49.1695"}
{"text": "Delta - tocotrienol is a natural Vitamin E compound that has been consumed by humans as a dietary supplement .The Food and Drug Administration ( FDA ) has not approved it for sale as a drug .", "label": "", "metadata": {}, "score": "49.192577"}
{"text": "The adverse event profile of the study participants is shown in Table 4 .The rate of adverse events in the vitamin C group during and two hours after intervention was 16/70 ( 22.9 % ) , which was not significantly different from that in the placebo group ( 11/71 , 15.4 % ) .", "label": "", "metadata": {}, "score": "49.52959"}
{"text": "She prepared solutions by mixing either vitamin C 10 g ( 20 ml ) or normal saline 20 ml in the normal saline bottle according to the randomization list , then had no further involvement in the study .", "label": "", "metadata": {}, "score": "49.753143"}
{"text": "Mean plasma levels of vitamins A , D , and E and -carotene remained within the reference range in all treatment groups throughout the 2-year study .", "label": "", "metadata": {}, "score": "50.81607"}
{"text": "The average difference in fatigue score between the vitamin C group and the placebo group was 0.85 ( fatigue score ) in our pilot study .", "label": "", "metadata": {}, "score": "50.87999"}
{"text": "There were no significant differences among treatment groups in serum triglyceride or glucose levels at any time .Fasting insulin levels in the 120-mg orlistat group were significantly lower than in the placebo group only after 52 weeks of treatment .", "label": "", "metadata": {}, "score": "51.337765"}
{"text": "An MDA - supported trial of high - dose ascorbic acid ( vitamin C ) in the type 1A form of Charcot - Marie - Tooth disease ( CMT ) ( CMT1A ) did not find a benefit for this treatment , although it appeared safe and was generally well - tolerated .", "label": "", "metadata": {}, "score": "51.33998"}
{"text": "Treatment was well tolerated , with no reported serious adverse events .Based on the results , Transport plans to initiate the next stage of development in 2008 .", "label": "", "metadata": {}, "score": "51.366554"}
{"text": "The purpose of this study is to determine the safest dose of the study drug Vitamin E Delta - tocotrienol , how often it should be taken , and how well people with pancreatic tumors tolerate Vitamin E Delta - tocotrienol .", "label": "", "metadata": {}, "score": "51.782234"}
{"text": "Repeated therapy was found to be generally safe and well tolerated with the exception of a significantly higher risk of vomiting following repeat treatment with DP within 2 - 4 weeks of a previous dose .", "label": "", "metadata": {}, "score": "51.877193"}
{"text": "Other Name : Delta - tocotrienol .Study Arm ( s ) .Experimental : Phase I Dose Escalation .Vitamin E \u03b4 - Tocotrienol will be administered orally as a single agent twice daily for 14 consecutive days and one dose on Day 15 .", "label": "", "metadata": {}, "score": "52.002815"}
{"text": "Discussion .The primary outcome , fatigue score ( assessing the level of \" fatigue right now \" ) , was significantly decreased in the vitamin C group compared to the placebo group .", "label": "", "metadata": {}, "score": "52.192474"}
{"text": "Yeom CH , Jung GC , Song KJ : Changes of terminal cancer patients ' health - related quality of life after high dose vitamin C administration .", "label": "", "metadata": {}, "score": "52.3453"}
{"text": "Patients then received the same treatment for a second year in combination with a weight - maintenance diet intended to prevent weight regain rather than induce further weight loss .", "label": "", "metadata": {}, "score": "52.40953"}
{"text": "Current Other Outcome Measures ICMJE .Not Provided .Original Other Outcome Measures ICMJE .Not Provided .Descriptive Information .Brief Title ICMJE .Vitamin E \u03b4 - Tocotrienol Administered to Subjects With Resectable Pancreatic Exocrine Neoplasia .", "label": "", "metadata": {}, "score": "52.6816"}
{"text": "Levine M , Rumsey SC , Daruwala R , Park JB , Wang Y : Criteria and recommendations for vitamin C intake .JAMA 1999 , 281 ( 15 ) : 1415 - 1423 .", "label": "", "metadata": {}, "score": "52.815365"}
{"text": "Under realistic clinical practice conditions , patients who relapsed would most likely be encouraged to reduce their energy intake for a period to reverse the weight regain .", "label": "", "metadata": {}, "score": "52.857166"}
{"text": "View Article .Padayatty SJ , Sun H , Wang Y , Riordan HD , Hewitt SM , Katz A , Wesley RA , Levine M : Vitamin C pharmacokinetics : implications for oral and intravenous use .", "label": "", "metadata": {}, "score": "52.916588"}
{"text": "This result reflects a significantly smaller relapse from weight loss in the patients treated with orlistat .CARDIOVASCULAR RISK FACTORS .Reductions in all lipid parameters were observed in all treatment groups during the placebo lead - in period , which reflects the short - term effect of energy restriction alone ( Table 4 ) .", "label": "", "metadata": {}, "score": "53.01963"}
{"text": "Padayatty SJ , Levine M : New insights into the physiology and pharmacology of vitamin C. CMAJ 2001 , 164 ( 3 ) : 353 - 355 .", "label": "", "metadata": {}, "score": "53.084766"}
{"text": "The largest decrease in weight was observed with the 120-mg dosage of orlistat .In the second year , the energy intake was increased to maintain body weight rather than induce further weight loss .", "label": "", "metadata": {}, "score": "53.11534"}
{"text": "We randomly assigned 73 participants to the vitamin C group , and 74 participants to the placebo group .The participants received a single intravenous treatment of either vitamin C ( 10 g ) or normal saline .", "label": "", "metadata": {}, "score": "53.558804"}
{"text": "This large 2-year double - blind placebo - controlled study , the first conducted in the primary care setting , emphasizes the advantage of diet plus pharmacotherapy with orlistat over dietary treatment alone .", "label": "", "metadata": {}, "score": "53.603043"}
{"text": "Results .Subject Compliance to the Clinical Trial .Of the 150 subjects initially recruited for the trial , 147 ( 74 in the vitamin C group , 73 in the placebo group ) were enrolled in the final study group .", "label": "", "metadata": {}, "score": "54.11931"}
{"text": "AL has been shown to be highly efficacious and well tolerated , and has become the most widely recommended first - line regimen in Africa [ 1 , 2 ] .", "label": "", "metadata": {}, "score": "55.01174"}
{"text": "Pretreatment and on - study evaluations included : history ; physical examination ; laboratory tests ; and analysis of tumor markers ( chromogranin A ) , serum VEGF , VEGF polymorphism , vitamin D , vitamin D polymorphism .", "label": "", "metadata": {}, "score": "55.51561"}
{"text": "No dietary adjustment was made for those whose weight remained stable .Registered dieticians or behavioral psychologists were not involved in nutritional or behavioral counseling at any stage of the study .", "label": "", "metadata": {}, "score": "55.789825"}
{"text": "Continuation of capecitabine therapy beyond 9 months was permitted according to the investigator 's discretion .Bevacizumab was given intravenously at a dose of 5 mg / kg every 2 weeks .", "label": "", "metadata": {}, "score": "55.911125"}
{"text": "Melia AT , Koss - Twardy SG , Zhi J. The effect of orlistat , an inhibitor of dietary fat absorption , on the absorption of vitamins A and E in healthy volunteers .", "label": "", "metadata": {}, "score": "56.037003"}
{"text": "J Pain Symptom Manage 2005 , 29 ( 2 ) : 165 - 172 .View Article .Kodama M , Kodama T : The clinical course of interstitial pneumonia alias chronic fatigue syndrome under the control of megadose vitamin C infusion system with dehydroepiandrosterone - cortisol annex .", "label": "", "metadata": {}, "score": "56.176598"}
{"text": "DIET AND PHYSICAL ACTIVITY .The reduced - energy diet prescribed during the 4-week lead - in period and the first 52 weeks of treatment was nutritionally balanced ; supplied about 30 % of energy as fat , 50 % as carbohydrate , and 20 % as protein ; and contained a maximum of 300 mg / d of cholesterol .", "label": "", "metadata": {}, "score": "56.615334"}
{"text": "10.1093/annonc / mdq328 View Article PubMed .Holick MF : Vitamin D deficiency .N Engl J Med 2007 , 19;357 ( 3 ) : 266 - 281 .", "label": "", "metadata": {}, "score": "56.91141"}
{"text": "We reduced subjective bias by using a validated measurement tool to assess fatigue [ 11 ] , and we detected significant differences in fatigue scores after adjustment of baseline values .", "label": "", "metadata": {}, "score": "57.44169"}
{"text": "The actual weight loss for patients who lost 5 % or more of initial body weight after 2 years ranged from 11.7 \u00b1 0.56 kg for the 120-mg orlistat group to 8.7 \u00b1 0.54 kg for the placebo group .", "label": "", "metadata": {}, "score": "57.571243"}
{"text": "These lipid variables improved significantly more in patients treated with 120-mg orlistat compared with placebo after the first year of the study .A progressive rise in these lipid levels during the second year of treatment with placebo was attenuated by orlistat .", "label": "", "metadata": {}, "score": "57.59411"}
{"text": "Two outliers ( one in each group ) for plasma vitamin C level were excluded from analysis .Our final data set , then , included 141 participants ( 70 in the vitamin C group , 71 in the placebo group )", "label": "", "metadata": {}, "score": "57.83444"}
{"text": "The addition of more intensive dietary counseling , psychosocial support , and lifestyle modification may produce greater efficacy in some patients .Nevertheless , 120 mg of orlistat provides a well - tolerated means of achieving sustained modest weight loss and improvement in selected risk factors for individuals whose obesity puts their health at risk 29 and offers primary care physicians a useful tool to treat obesity .", "label": "", "metadata": {}, "score": "57.848183"}
{"text": "In the general population , an inverse association was found between the level of vitamin D and the prevalence of albuminuria [ 25 ] .These observations encouraged us to explore whether vitamin D status might be associated with the onset of bevacizumab - induced proteinuria .", "label": "", "metadata": {}, "score": "58.46089"}
{"text": "Long - term safety data were positive with treatment well tolerated and no adverse events reported .Efficacy data collected demonstrated that the engineered stem cells were able to survive long term in vivo and to produce CD4 + cell progeny containing functioning antisense genes .", "label": "", "metadata": {}, "score": "58.797844"}
{"text": "Biochemical and symptomatic responses were observed in 52.9 % and 82.3 % of cases , respectively .The treatment was well tolerated .Grade 3 toxicities included hand and foot syndrome ( 11.1 % ) , proteinuria ( 4.4 % ) , and renal toxicity ( 2.2 % ) .", "label": "", "metadata": {}, "score": "59.184166"}
{"text": "To our knowledge , proteinuria as a predictive factor of bevacizumab efficacy has been suggested only in a case report to date [ 13 ] but was never demonstrated in a prospective study .", "label": "", "metadata": {}, "score": "59.190704"}
{"text": "However , these events were generally mild to moderate in intensity , usually occurred no more than twice in any patient , and rarely led to the withdrawal of treatment .", "label": "", "metadata": {}, "score": "59.282852"}
{"text": "The cost of this regimen is similar to that of other molecular target agents currently used in the management of neuroendocrine tumors .In our opinion , the XELBEVOCT regimen merits further testing in prospective phase 3 trials .", "label": "", "metadata": {}, "score": "59.394585"}
{"text": "To avoid unexpected adverse reactions , the least dose for the high dose is ideal and we referred a preceding domestic study [ 13 ] .", "label": "", "metadata": {}, "score": "59.527084"}
{"text": "This study contributes to a body of literature suggesting that AL and DP are both safe and well tolerated across a wide range of epidemiological settings .", "label": "", "metadata": {}, "score": "60.03701"}
{"text": "Biochemical response was evaluated in patients with elevated markers at baseline .Safety was assessed according to Common Toxicity Criteria , version 3.0 .Statistical analyses .", "label": "", "metadata": {}, "score": "60.129295"}
{"text": "Determine the plasma pharmacokinetic ( PK ) and estimate renal elimination of Vitamin E \u03b4 - Tocotrienol and its putative metabolite .[ Time Frame : 12 weeks per participant ] [ Designated as safety issue : Yes ] .", "label": "", "metadata": {}, "score": "60.536076"}
{"text": "Patients completed 3-day dietary records at 10 points during the study .At week 4 , patients received brief instructions on how to complete the food intake records from the physicians and their staff and viewed an instructional video on food records for reinforcement .", "label": "", "metadata": {}, "score": "60.556698"}
{"text": "Patients with severe fatigue , such as cancer inpatients , and patients at risk for vitamin C deficiency , would exhibit better responses .List of abbreviations .", "label": "", "metadata": {}, "score": "60.919937"}
{"text": "From our trial it seems that toxicity is dose - dependent : administration of 2000 mg / day was associated with the occurrence of G3 hand and foot syndrome in 11 % of patients , at variance with no G3 with 1500 mg / day used in another study [ 20 ] .", "label": "", "metadata": {}, "score": "61.142174"}
{"text": "After 2 years of treatment , LDL cholesterol levels remained significantly lower in both orlistat - treated groups compared with placebo , and this likely reflects an independent lipid - lowering effect of orlistat rather than simply a weight - loss effect per se .", "label": "", "metadata": {}, "score": "61.35561"}
{"text": "Dietary intervention is the most common treatment modality for obesity in the primary care setting .However , while diet and lifestyle intervention alone is effective in producing short - term weight loss ( 6 months ) , these treatments rarely result in long - term ( 1 or 2 years ) sustained weight loss or weight maintenance .", "label": "", "metadata": {}, "score": "61.499794"}
{"text": "Plasma concentrations of vitamin C following oral administration are not dose - dependent , and are instead subject to a plateau .Vitamin C distribution after oral delivery is tightly controlled by intestinal absorption , transport to tissues , and renal reabsorption and excretion [ 19 , 20 ] .", "label": "", "metadata": {}, "score": "61.55812"}
{"text": "We determined oxidative stress levels ( Free Oxygen Radicals Test ( FORT ) by Free Oxygen Radicals Monitor Plus , Callegari , Italy ) and measured plasma vitamin C concentration ( by High Performance Liquid Chromatography , HPLC ) at baseline and two hours after the trial .", "label": "", "metadata": {}, "score": "61.57551"}
{"text": "Efficacy data were analyzed on an intent - to - treat ( ITT ) basis ( ie , the ITT population was defined as all patients who were randomized to treatment groups , received at least 1 dose of double - blind medication , and had at least 1 follow - up body weight measurement ) .", "label": "", "metadata": {}, "score": "61.659805"}
{"text": "No skin lesions resembling those noted in nonclinical studies of other DPP-4 inhibitors were observed .Hypoglycemia was rare ( 1.5 - 3.0 % ) , and no hypoglycemic event was considered an adverse event or was severe enough to require assistance .", "label": "", "metadata": {}, "score": "61.824226"}
{"text": "Use And Costs Of Bariatric Surgery And Prescription Weight - Loss Medications Encinosa et al .Health Aff ( Millwood ) 2005;24:1039 - 1046 .Effects of Weight Loss in Overweight / Obese Individuals and Long - Term Hypertension Outcomes : A Systematic Review Aucott et al .", "label": "", "metadata": {}, "score": "61.837505"}
{"text": "Effects of Weight Loss With Orlistat on Glucose Tolerance and Progression to Type 2 Diabetes in Obese Adults Heymsfield et al .Arch Intern Med 2000;160:1321 - 1326 .", "label": "", "metadata": {}, "score": "61.92215"}
{"text": "Further studies are needed to demonstrate the long - term health consequences and cost benefit of multiple risk factor reduction .Orlistat was well tolerated .", "label": "", "metadata": {}, "score": "62.013958"}
{"text": "There were no significant differences in adverse events between the two treatment arms , although recent treatment with DP was associated with an increased risk of vomiting .", "label": "", "metadata": {}, "score": "62.019363"}
{"text": "Pancreatic Neoplasms .Intervention ICMJE .Drug : Vitamin E \u03b4 - Tocotrienol .Vitamin E \u03b4 - Tocotrienol is supplied as 100-mg , 200-mg , and 400-mg capsules .", "label": "", "metadata": {}, "score": "62.05275"}
{"text": "View Article .Sanchez - Moreno C , Cano MP , de Ancos B , Plaza L , Olmedilla B , Granado F , Martin A : Consumption of high - pressurized vegetable soup increases plasma vitamin C and decreases oxidative stress and inflammatory biomarkers in healthy humans .", "label": "", "metadata": {}, "score": "62.264374"}
{"text": "No conclusions can be drawn from this small patient sample ; nonetheless , hypovitaminosis D status was associated with a gain in progression - free survival ( approaching statistical significance ) , and this contrasts with previously published data showing a negative prognostic role of hypovitaminosis D [ 26 ] .", "label": "", "metadata": {}, "score": "62.37532"}
{"text": "J. Clin .Nutr .A Comparison of Meal Replacements and Medication in Weight Maintenance after Weight Loss LeCheminant et al .J. Am .Coll .", "label": "", "metadata": {}, "score": "62.563076"}
{"text": "The prescribed energy intake was 5020 kJ / d for patients who weighed less than 90 kg initially and 6275 kJ / d for those who weighed 90 kg or more initially .", "label": "", "metadata": {}, "score": "62.83822"}
{"text": "FREE FULL TEXT .Hyman FN , Sempos E , Saltsman J , Glinsmann WH .Evidence for success of caloric restriction in weight loss and control : summary of data from industry .", "label": "", "metadata": {}, "score": "62.94077"}
{"text": "Results of the food record analyses were not given to the physicians or subjects until they had completed the study .EFFICACY MEASUREMENTS .The primary efficacy parameter was the change in body weight .", "label": "", "metadata": {}, "score": "63.162857"}
{"text": "Third , we found no significant relationship between fatigue and oxidative stress .Our participants were healthy adults , so their oxidative stress and fatigue levels might have been too low to demonstrate a clear relationship .", "label": "", "metadata": {}, "score": "63.384624"}
{"text": "RESEARCH DESIGN AND METHODS- .Patients received counseling on diet and exercise .Additional antidiabetes agents were prohibited .Efficacy assessments included all randomized patients who received the double - blind study drug .", "label": "", "metadata": {}, "score": "63.390327"}
{"text": "In summary , the efficacy and safety of alogliptin monotherapy were comparable with those of other DPP-4 inhibitors ( 9 - 15 ) .Alogliptin represents an effective treatment option whether given alone or in combination with antihyperglycemic agents from other classes .", "label": "", "metadata": {}, "score": "63.393288"}
{"text": "The absence of randomization precluded determining whether the addition of bevacizumab was synergistic with capecitabine or not .The response rate obtained in this study was similar to that observed in our previous trial with octreotide LAR plus continuous 5-fluorouracil infusion [ 17 ] , but the progression - free survival was shorter .", "label": "", "metadata": {}, "score": "63.418915"}
{"text": "Low - Dose Orlistat Effects on Body Weight of Mildly to Moderately Overweight Individuals : A 16 Week , Double - Blind , Placebo - Controlled Trial Anderson et al .", "label": "", "metadata": {}, "score": "63.466354"}
{"text": "10.1053/j.ajkd.2007.04.015 View Article PubMed .Buttigliero C , Monagheddu C , Petroni P , Saini A , Dogliotti L , Ciccone G , Berruti A : Prognostic role of vitamin D status and efficacy of vitamin D supplementation in cancer patients : a systematic review .", "label": "", "metadata": {}, "score": "63.4915"}
{"text": "Participants were actively monitored for adverse events for 28 days and then passively for up to 63 days after treatment .This study was registered in ClinicalTrials.gov ( registration # NCT00527800 ) .", "label": "", "metadata": {}, "score": "63.526474"}
{"text": "The study demonstrates that the lipid emulsion containing four different types of oils is safe and well tolerated in long - term PN .BACKGROUND & AIM : Long - term safety and efficacy of a lipid emulsion containing soybean oil , medium - chain triglycerides ( MCT ) , olive oil and fish oil and enriched in vitamin E have not yet been evaluated in adult patients requiring long - term parenteral nutrition ( PN ) .", "label": "", "metadata": {}, "score": "63.74633"}
{"text": "The safety population included patients who took at least one dose of the study drug ( double blind ) .Safety assessments included adverse events , clinical laboratory findings , 12-lead electrocardiograms , physical examination findings , vital signs , and hypoglycemic events .", "label": "", "metadata": {}, "score": "63.932877"}
{"text": "The results demonstrate that the use of orlistat in this setting produced significantly greater weight loss than placebo after 1 year of treatment .Moreover , weight regain was diminished by orlistat during the second year of treatment , maintaining a significant difference from placebo after 2 years .", "label": "", "metadata": {}, "score": "64.17227"}
{"text": "Trial Registration .Keywords .vitamin C office workers fatigue .Background .Fatigue is one of the most common complaints in daily life , and the prevalence of fatigue is high in full - time workers .", "label": "", "metadata": {}, "score": "64.3099"}
{"text": "Reactive oxygen species .ANCOVA : .Analysis of covariance .FORT : .Free Oxygen Radicals Test .Declarations .Acknowledgements .This study was supported by the Korean Association for Vitamin Research .", "label": "", "metadata": {}, "score": "64.59497"}
{"text": "Maintenance bevacizumab treatment until progression or unacceptable toxicity was prescribed in patients at the individual investigator 's discretion .Bevacizumab was permanently withdrawn if grade 4 hypertension or grade 4 thrombosis occurred .", "label": "", "metadata": {}, "score": "64.71495"}
{"text": "Treatment was self administered at the first signs and symptoms of a herpatic lesion .The treatment phase ended after eighty subjects in each group had herpatic recurrence and received treatment .", "label": "", "metadata": {}, "score": "65.03819"}
{"text": "Scott R , Wu M , Sanchez M , Stein P : Efficacy and tolerability of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy over 12 weeks in patients with type 2 diabetes .", "label": "", "metadata": {}, "score": "65.11243"}
{"text": "The most common adverse event in both groups was itching and/or pain at the injection site .There were no serious adverse events , nor were there adverse events that required treatment .", "label": "", "metadata": {}, "score": "65.27582"}
{"text": "Table 3 .Comparison of fatigue between the two groups within subgroups categorized by baseline vitamin C level .Higher and Lower groups were divided by 50th percentile ( 10.95 \u03bcg / ml in trial group , 11.95 \u03bcg / ml in placebo group ) of baseline plasma vitamin C level .", "label": "", "metadata": {}, "score": "65.47635"}
{"text": "We randomly assigned participants to vitamin C and placebo groups .A computerized randomization list was generated by a statistician , sealed in an opaque envelope , and delivered to a study nurse .", "label": "", "metadata": {}, "score": "65.553116"}
{"text": "Treatment administered and adverse events .Capecitabine treatment was administered for a median duration of 9 months ( range , 1 - 11 ) .Treatment with metronomic capecitabine and bevacizumab and concomitant octreotide LAR was generally well tolerated .", "label": "", "metadata": {}, "score": "65.632065"}
{"text": "View Article PubMed .Karachaliou N , Saloustros E , Vamvakas L , Mavroudis D , Georgoulias V : Proteinuria and favourable clinical response in a patient receiving paclitaxel + bevacizumab for metastatic breast cancer .", "label": "", "metadata": {}, "score": "65.953186"}
{"text": "Toxicity as a predictive factor of treatment efficacy .Effect of hypertension ( a ) and proteinuria ( b ) on time to progression .VEGF and VEGF polymorphisms as predictors of bevacizumab toxicity and efficacy .", "label": "", "metadata": {}, "score": "66.09274"}
{"text": "Following the initial 28-day active surveillance period , participants were asked to return to the clinic only when they desired medical attention .Passive surveillance for adverse events continued until the participant was re - treated with study drugs ( at which time a new cycle of adverse event assessment began ) , the end of the study period ( September 2008 ) , or withdrawal from the study .", "label": "", "metadata": {}, "score": "66.12184"}
{"text": "CONCLUSIONS- .Alogliptin monotherapy administered for 26 weeks to treatment - na\u00efve patients with type 2 diabetes produced significant and clinically meaningful improvements in A1C. Glycemic improvements with alogliptin were rapid , sustained , and independent of age , race , and sex .", "label": "", "metadata": {}, "score": "66.225815"}
{"text": "Younger age was associated with an increased risk of diarrhoea in both the AL and DP treatment arms .There was no increase in the risk of diarrhoea or vomiting for children who were HIV - infected or on concomitant therapy with antiretrovirals or trimethoprim - sulphamethoxazole prophylaxis .", "label": "", "metadata": {}, "score": "66.22961"}
{"text": "Octreotide LAR therapy was administered at a dose of 20 mg every 4 weeks .Capecitabine was administered orally on a metronomic schedule at a dose of 1000 mg twice daily without interruption for a maximum of 9 months .", "label": "", "metadata": {}, "score": "66.26703"}
{"text": "A low incidence of hypoglycemia occurred with alogliptin and with placebo .Weight gain is common among patients taking sulfonylureas and thiazolidinediones and may reduce treatment adherence ( 7 , 8 ) ; thus , the weight neutrality of alogliptin and other DPP-4 inhibitors may offer a therapeutic advantage ( 9 - 15 ) .", "label": "", "metadata": {}, "score": "66.274185"}
{"text": "VEGF polymorphisms were not associated with patient outcome .Conclusion .The XELBEVOCT regimen is active and well tolerated in patients with metastatic WMD - NEN .", "label": "", "metadata": {}, "score": "66.581024"}
{"text": "Capecitabine administration was delayed for at least 1 week in 12 patients ( 26.7 % ) and for 2 weeks in 16 patients ( 35.6 % ) .", "label": "", "metadata": {}, "score": "66.744064"}
{"text": "Details of the study procedures have been published previously and are summarized here [ 11 ] .Study participants were followed for all of their health needs in a dedicated study clinic .", "label": "", "metadata": {}, "score": "66.74883"}
{"text": "Analysis of adverse events during passive surveillance was limited to 63 days because this is typically the longest duration of follow - up used in anti - malarial clinical trials and likely captures the majority of adverse events causally related to study drugs [ 11 ] .", "label": "", "metadata": {}, "score": "66.806274"}
{"text": "ABSTRACT .Zhi J , Melia AT , Koss - Twardy SG , Arora S , Patel IH .The effect of orlistat , an inhibitor of dietary fat absorption , on the pharmacokinetics of beta - carotene in healthy volunteers .", "label": "", "metadata": {}, "score": "66.96243"}
{"text": "There were several limitations to this study .Firstly , although every effort was made to apply standardized definitions for adverse events , treatment assignment was not blinded and results were limited by largely subjective reports of symptoms from parents or guardians .", "label": "", "metadata": {}, "score": "67.01212"}
{"text": "Meta - Analysis : Pharmacologic Treatment of Obesity Li et al .ANN INTERN MED 2005;142:532 - 546 .Changes in body weight and serum lipid profile in obese patients treated with orlistat in addition to a hypocaloric diet : a systematic review of randomized clinical trials Hutton and Fergusson Am .", "label": "", "metadata": {}, "score": "67.07212"}
{"text": "There were no statistically significant differences in the risks of these adverse events between the treatment arms for any time interval .Table 2 .Risk of common adverse events for discrete time periods following initiation of therapy .", "label": "", "metadata": {}, "score": "67.23695"}
{"text": "Roth , D.E. ; Mahmud , A.A. ; Raqib , R. ; Akhtar , E. ; Black , R.E. ; Baqui , A.H. Pharmacokinetics of High - Dose Weekly Oral Vitamin D3 Supplementation during the Third Trimester of Pregnancy in Dhaka , Bangladesh .", "label": "", "metadata": {}, "score": "67.247406"}
{"text": "Secondary efficacy parameters included serum lipid levels ( total cholesterol , low - density lipoprotein [ LDL ] cholesterol , high - density lipoprotein [ HDL ] cholesterol , the LDL / HDL ratio , and triglycerides ) ; fasting serum glucose and insulin levels ; blood pressure ; and waist circumference .", "label": "", "metadata": {}, "score": "67.26303"}
{"text": "ABSTRACT .Over - the - counter weight loss with orlistat ?DTB 2009;47:125 - 127 .Differences between human subjects in the composition of the faecal bacterial community and faecal metabolism of linoleic acid Devillard et al .", "label": "", "metadata": {}, "score": "67.29633"}
{"text": "None of the patients had received any type of chemotherapy , 19/45 patients ( 42.2 % ) had been previously treated with somatostatin analogues , and 23/45 patients ( 51.1 % ) with radionuclide therapy before entering the study .", "label": "", "metadata": {}, "score": "67.3049"}
{"text": "TOLERABILITY .In general , adverse events in all groups were transient , mild , or moderate in intensity and resolved without intervention .With the exception of GI events , the incidence and type of adverse events were similar in all treatment groups .", "label": "", "metadata": {}, "score": "67.337265"}
{"text": "The patients wore indoor street clothes and no shoes for the body weight measurement .Patients were weighed at least twice at each assessment until consecutive measurements were within 0.5 kg of each other ; the average of the 2 measurements was recorded .", "label": "", "metadata": {}, "score": "67.40229"}
{"text": "However , the difference between treatment with placebo and orlistat ( ie , the treatment effect ) was greater in the present study .These observations support the hypothesis that partial inhibition of dietary fat absorption produces a significant energy deficit , leading to weight loss , and this indicates that orlistat is a useful addition to standard dietary therapy in the primary care setting .", "label": "", "metadata": {}, "score": "67.557465"}
{"text": "Results for secondary efficacy measures and exploratory assessments are summarized in Table 1 .Overall incidences of adverse events ( 67.4 - 70.3 % ) and proportions of patients who discontinued because of adverse events ( 1.5 - 2.3 % ) were similar across treatment groups .", "label": "", "metadata": {}, "score": "67.70183"}
{"text": "Eicosapentaenoic acid , docosahexaenoic acid and n-3/n-6 fatty acid ratio increased in the SMOF group , while they remained unchanged in the control in plasma and RBC .", "label": "", "metadata": {}, "score": "67.789116"}
{"text": "Although it is desirable to perform some screening test such as blood chemistry panel , we excluded subjects having chronic disease by past medical history .", "label": "", "metadata": {}, "score": "68.141754"}
{"text": "Serious adverse events occurred without relation to dose ( 12.5 mg , 3.8 % ; 25 mg , 0.8 % ; and placebo , 3.1 % ) and were considered unrelated to treatment .", "label": "", "metadata": {}, "score": "68.318"}
{"text": "The trial met the primary endpoint of statistical non-inferiority with 85 % of the PULSYS group achieving bacterial eradication versus 83.4 % of the penicillin group .", "label": "", "metadata": {}, "score": "68.4266"}
{"text": "Pratley RE , Jauffret - Kamel S , Galbreath E , Holmes D : Twelve - week monotherapy with the DPP-4 inhibitor vildagliptin improves glycemic control in subjects with type 2 diabetes .", "label": "", "metadata": {}, "score": "68.42882"}
{"text": "Table 2 .Comparison of fatigue , plasma vitamin C levels , and oxidative stress between the two groups .Boxplots of fatigue scores in the two groups .", "label": "", "metadata": {}, "score": "68.5753"}
{"text": "10 - 12 Several studies suggest that adjunctive pharmacotherapy in combination with medical nutritional therapy improves long - term efficacy ; however , some of these medications , now withdrawn , have been associated with serious adverse effects .", "label": "", "metadata": {}, "score": "68.59526"}
{"text": "Values presented are mean \u00b1 SEM unless otherwise indicated .Of the 796 patients initially enrolled in the study ( Figure 1 ) , 635 ( 80 % ) completed the placebo lead - in period .", "label": "", "metadata": {}, "score": "68.66034"}
{"text": "DP has also been shown to be very safe and well tolerated in studies from Asia and Africa .In a review of 2,600 patients from studies primarily done in Asia , gastrointestinal complaints were the most common adverse events associated with DP , with no evidence of severe drug toxicity [ 5 ] .", "label": "", "metadata": {}, "score": "68.67352"}
{"text": "Hollander PA , Elbein SC , Hirsch IB , et al .Role of orlistat in the treatment of obese patients with type 2 diabetes : a 1-year randomized double - blind study .", "label": "", "metadata": {}, "score": "68.97345"}
{"text": "Results presented here include detailed data on the safety and tolerability of these therapies with follow - up extended for two additional months , in the context of repeated treatments , HIV co - infection , and the concomitant use of trimethoprim - sulphamethoxazole ( TS ) prophylaxis and anti - retroviral ( ARV ) therapy .", "label": "", "metadata": {}, "score": "68.99725"}
{"text": "References .Bosman A , Mendis K : A major transition in malaria treatment : The adoption and deployment of artemisinin - based combination therapies .", "label": "", "metadata": {}, "score": "69.25224"}
{"text": "The last observation carried forward method was used for imputing missing data ; testing was two - sided at a significance level of 0.05 .Continuous secondary efficacy analyses were performed as for the primary analysis , except that the baseline covariate corresponds with the tested end point .", "label": "", "metadata": {}, "score": "69.43216"}
{"text": "Ten patients ( 4.7 % ) in the 60-mg orlistat group and 12 ( 5.7 % ) in the 120-mg orlistat group withdrew from the study prematurely because of GI events , compared with 3 patients ( 1.4 % ) in the placebo group .", "label": "", "metadata": {}, "score": "69.60602"}
{"text": "The proportion of elevated CgA levels was unevenly distributed across the 3 patient subgroups .Clinical activity .Forty - four out of the 45 consecutively enrolled patients could be assessed for response ; the remaining patient withdrew consent to continue the experimental treatment after the first cycle and so could not be assessed .", "label": "", "metadata": {}, "score": "69.6137"}
{"text": "Serious adverse events were rare .Of note , one patient developed severe anaemia twice following treatment with DP .This patient was removed from the study protocol because of initial concerns about a causal relationship between DP and severe anaemia .", "label": "", "metadata": {}, "score": "69.83725"}
{"text": "Hypovitaminosis D is highly prevalent in cancer patients .It has been reported to increase the risk of cardiovascular diseases and mortality in such patients [ 14 ] and to promote proteinuria in patients with type 2 diabetes [ 15 ] .", "label": "", "metadata": {}, "score": "69.90735"}
{"text": "Because of their limited aggressiveness , WMD - NEN are notoriously resistant to standard chemotherapy and are usually addressed with biological target therapies [ 5 ] .", "label": "", "metadata": {}, "score": "70.18938"}
{"text": "Gaithersburg , Md : Aspen Publishers Inc ; 1997:557 - 597 .Davidson MH , Hauptman J , DiGirolamo M , et al .Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat : a randomized controlled trial .", "label": "", "metadata": {}, "score": "70.19571"}
{"text": "Considering 28-day outcomes , 715 ( 85 % ) completed follow - up without recurrent malaria , 106 ( 13 % ) had recurrent malaria , and 16 ( 2 % ) had incomplete follow - up .", "label": "", "metadata": {}, "score": "70.216774"}
{"text": "Weijl NI , Elsendoorn TJ , Lentjes EG , Hopman GD , Wipkink - Bakker A , Zwinderman AH , Cleton FJ , Osanto S : Supplementation with antioxidant micronutrients and chemotherapy - induced toxicity in cancer patients treated with cisplatin - based chemotherapy : a randomised , double - blind , placebo - controlled study .", "label": "", "metadata": {}, "score": "70.32617"}
{"text": "\" Nutrients 5 , no .3 : 788 - 810 .Objective To evaluate the long - term efficacy and tolerability within primary care settings of orlistat , a gastrointestinal lipase inhibitor , for the treatment of obesity .", "label": "", "metadata": {}, "score": "70.36848"}
{"text": "PMID : 22796064 Owner : NLM Status : Publisher .Abstract / OtherAbstract : .PRECIS : The aim of this study was to evaluate the safety and tolerance of a soybean / MCT / olive / fish oil emulsion in intestinal failure patients on long - term parenteral nutrition .", "label": "", "metadata": {}, "score": "70.36928"}
{"text": "In this study , the combination of octreotide LAR plus metronomic capecitabine and bevacizumab was active in the management of patients with metastatic WMD - NEN , the treatment was well tolerated , and the majority of the patients completed the treatment plan .", "label": "", "metadata": {}, "score": "70.42209"}
{"text": "View Article .Richards RS , Roberts TK , McGregor NR , Dunstan RH , Butt HL : Blood parameters indicative of oxidative stress are associated with symptom expression in chronic fatigue syndrome .", "label": "", "metadata": {}, "score": "70.690186"}
{"text": "State of the Art Review : Long - term Pharmacotherapy for Overweight and Obesity : A Review of Sibutramine , Orlistat , and Rimonabant Dunican et al .", "label": "", "metadata": {}, "score": "70.72107"}
{"text": "Outcomes and Follow - up .We measured the fatigue score using a numeric rating scale ( 0 - 10 ) , with current fatigue ( described as \" fatigue right now \" ) as a primary outcome [ 11 ] .", "label": "", "metadata": {}, "score": "70.76288"}
{"text": "In summary , both AL and DP were safe and well tolerated for the treatment of uncomplicated malaria in a cohort of children uniquely characterized by their young age , repeated therapy , and the inclusion of HIV - exposed and HIV - infected patients .", "label": "", "metadata": {}, "score": "70.81888"}
{"text": "After a 4-week single - blind , placebo lead - in period , 635 patients were randomized to receive placebo , 60 mg of orlistat TID , or 120 mg of orlistat TID with main meals for 52 weeks .", "label": "", "metadata": {}, "score": "70.878586"}
{"text": "Participating physicians did not receive any specific training in nutrition or weight management techniques beyond the same instructional materials given to the patients ( see below ) .", "label": "", "metadata": {}, "score": "70.9158"}
{"text": "Cannabinoid-1 Receptor Antagonist , Rimonabant , for Management of Obesity and Related Risks Gadde and Allison Circulation 2006;114:974 - 984 .FULL TEXT .Obesity in older adults : technical review and position statement of the American Society for Nutrition and NAASO , The Obesity Society Villareal et al .", "label": "", "metadata": {}, "score": "71.032005"}
{"text": "Serious adverse events were reported by 27 % of the TMC125 group and 18 % of the control group .Efficacy data revealed that mean change from baseline in viral load at week 48 for the TMC125 400 mg and 800 mg bid and active control groups was -0.88 , -1.01 and -0.14 log10 copies / ml , respectively .", "label": "", "metadata": {}, "score": "71.03795"}
{"text": "This article is published under license to BioMed Central Ltd. Abstract .Background .We assessed the activity and toxicity of the XELBEVOCT regimen in patients with metastatic well - to - moderately differentiated neuroendocrine neoplasms ( WMD - NEN ) .", "label": "", "metadata": {}, "score": "71.4307"}
{"text": "Conclusion .In conclusion , XELBEVOCT is an active and well - tolerated regimen in the management of metastatic WMD - NEN .Proteinuria correlated with hypovitaminosis D status and was the best predictive factor of treatment efficacy .", "label": "", "metadata": {}, "score": "71.55711"}
{"text": "Adverse events from the most commonly observed categories occurred with similar or lower frequency in those given alogliptin versus placebo ( infection , 28.0 - 37.6 % ; gastrointestinal , 12.1 - 14.3 % ) .", "label": "", "metadata": {}, "score": "71.68968"}
{"text": "Eur J Cancer 2010 , 46 ( 2 ) : 439 - 448 .10.1016/j.ejca.2009.11.001 View Article PubMed . de Boer IH , Ioannou GN , Kestenbaum B , Brunzell JD , Weiss NS : 25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey ( NHANES III ) .", "label": "", "metadata": {}, "score": "71.8887"}
{"text": "Dejager S , Razac S , Foley JE , Schweizer A : Vildagliptin in drug - na\u00efve patients with type 2 diabetes : a 24-week , double - blind , randomized , placebo - controlled , multiple - dose study .", "label": "", "metadata": {}, "score": "71.983696"}
{"text": "When the patients were grouped according to the response obtained , the progression - free survival was 14.9 ( 95 % CI , 2.4 - 38.6 ) in those who attained a partial response or stable disease and 11.4 ( 95 % CI , 0.0 - 25 ) in those with disease progression .", "label": "", "metadata": {}, "score": "72.01222"}
{"text": "Bolen S , Feldman L , Vassy J , Wilson L , Yeh HC , Marinopoulos S , Wiley C , Selvin E , Wilson R , Bass EB , Brancati FL : Systematic review : comparative effectiveness and safety of oral medications for type 2 diabetes mellitus .", "label": "", "metadata": {}, "score": "72.070145"}
{"text": "There were no significant differences in the initial characteristics of the placebo and orlistat treatment groups .Four hundred twenty - seven patients completed the first year of double - blind treatment ( 122 [ 57 % ] received placebo , 154 [ 72 % ] received 60 mg of orlistat , and 151 [ 72 % ] received 120 mg of orlistat ) .", "label": "", "metadata": {}, "score": "72.21712"}
{"text": "Despite increased surveillance for skin - related adverse events , their overall incidence remained low ( 12.5 % ) , albeit higher with alogliptin ( 12.8 - 15.2 % ) than with placebo ( 6.3 % ) , mostly because of pruritic events .", "label": "", "metadata": {}, "score": "72.363335"}
{"text": "Sato K , Ozaki H , Salamon CM , Christopher RJ , Yamamoto M : Lack of dermal toxicity with the highly selective dipeptidyl peptidase-4 inhibitor alogliptin in monkeys ( Abstract ) .", "label": "", "metadata": {}, "score": "72.409134"}
{"text": "FREE FULL TEXT .Zhi J , Melia AT , Guerciolini R , Chung J , Kingberg J , Hauptman JR .Retrospective population - based analysis of the dose - response ( fecal fat excretion ) relationship of orlistat in normal and obese volunteers .", "label": "", "metadata": {}, "score": "72.56191"}
{"text": "Agarwal R : Vitamin D , proteinuria , diabetic nephropathy , and progression of CKD .Clin J Am Soc Nephrol 2009 , 4 ( 9 ) : 1523 - 1528 .", "label": "", "metadata": {}, "score": "72.64982"}
{"text": "Exploratory end points included changes in measures of pancreatic function ( fasting insulin , fasting proinsulin , and homeostasis model assessment of \u03b2 - cell function ) and lipid profiles .", "label": "", "metadata": {}, "score": "72.68504"}
{"text": "Comparisons of adverse events due to anaemia after 28 days of follow - up were modeled with a binomial distribution using generalized estimating equations , adjusting for repeated measures in the same study participant with exchangeable correlation and robust standard errors .", "label": "", "metadata": {}, "score": "72.804504"}
{"text": "Drent ML , Larsson I , William - Olsson T , et al .Orlistat ( Ro 18 - 0647 ) , a lipase inhibitor , in the treatment of human obesity : a multiple dose study .", "label": "", "metadata": {}, "score": "72.880035"}
{"text": "More recently , target drugs , such as sunitinib and everolimus , have been shown to be efficacious in the management of pancreatic WMD - NEN [ 8 , 9 ] .", "label": "", "metadata": {}, "score": "73.01027"}
{"text": "ABSTRACT .Pharmacotherapeutic Options for Overweight Adolescents Dunican et al .The Annals of Pharmacotherapy 2007;41:1445 - 1455 .Rimonabant : A novel selective cannabinoid-1 receptor antagonist for treatment of obesity Patel and Pathak Am J Health Syst Pharm 2007;64:481 - 489 .", "label": "", "metadata": {}, "score": "73.0654"}
{"text": "Advancis Pharmaceutical announced positive results from a phase III trial of Amoxicillin , for the treatment of pharyngitis / tonsillitis due to Group A streptococcal infections .", "label": "", "metadata": {}, "score": "73.0681"}
{"text": "The patient has had prior major surgery within 30 days prior to first dose of study drug .The patient has uncontrolled intercurrent illness including , but not limited to , ongoing or active infection , hypertension , symptomatic congestive heart failure , unstable angina pectoris , cardiac arrhythmia , or psychiatric illness / social situations that would limit compliance with study requirements .", "label": "", "metadata": {}, "score": "73.28875"}
{"text": "Primary efficacy end point was mean change from baseline in A1C at the final visit .Overall , incidences of adverse events ( 67.4 - 70.3 % ) and hypoglycemia ( 1.5 - 3.0 % ) were similar across treatment groups .", "label": "", "metadata": {}, "score": "73.56363"}
{"text": "Patient population .The study opened for enrollment in November 2006 and closed to accrual in April 2009 when 45 consecutive patients were enrolled at five participating centers .", "label": "", "metadata": {}, "score": "73.6391"}
{"text": "The baseline characteristics of participants are shown in Table 1 .There were no demographical differences between two groups .Lifestyles can influence fatigue ; however , it did not differ between the two groups .", "label": "", "metadata": {}, "score": "73.67903"}
{"text": "As expected from the mechanism , the incidence of GI events was higher in the orlistat groups .Most GI events were mild to moderate in intensity , were limited to only 1 or 2 episodes per patient , and occurred early during treatment .", "label": "", "metadata": {}, "score": "73.72079"}
{"text": "Prince MI , Mitchison HC , Ashley D , Burke DA , Edwards N , Bramble MG , James OF , Jones DE : Oral antioxidant supplementation for fatigue associated with primary biliary cirrhosis : results of a multicentre , randomized , placebo - controlled , cross - over trial .", "label": "", "metadata": {}, "score": "73.73047"}
{"text": "The main end point of the study was the best change in tumor size at any time point during therapy .The upper limit of second - stage rejection was 7 responses observed out of 36 patients enrolled .", "label": "", "metadata": {}, "score": "73.77325"}
{"text": "Methods .This prospective phase 2 study included 45 patients with WMD - NEN arising from various primary sites .The treatment regimen was octreotide long - acting release ( LAR ) , 20 mg monthly , metronomic capecitabine , 2000 mg / daily , and intravenous bevacizumab , 5 mg / kg every 2 weeks , without interruption for 9 months .", "label": "", "metadata": {}, "score": "73.83584"}
{"text": "17 - 18 The efficacy of orlistat has been further established in a 2-year placebo - controlled trial that combined orlistat with lifestyle intervention by physicans who specialize in treating obesity , and in a 1-year placebo - controlled study of patients with type 2 diabetes treated with oral sulfonylurea medications .", "label": "", "metadata": {}, "score": "73.8517"}
{"text": "The most common adverse events considered to be related to the study drugs were nausea / vomiting , diarrhea , hand and foot syndrome , hypertension , proteinuria , and asthenia .", "label": "", "metadata": {}, "score": "73.9207"}
{"text": "View Article PubMed .Bakshi R , Hermeling - Fritz I , Gathmann I , Alteri E : An integrated assessment of the clinical safety of artemether - lumefantrine : A new oral fixed - dose combination antimalarial drug .", "label": "", "metadata": {}, "score": "74.067"}
{"text": "View Article .J Clin Oncol 2008 , 26 : 76 - 82 .10.1200/JCO.2007.12.1939 View Article PubMed .Dellapasqua S , Bertolini F , Bagnardi V , Campagnoli E , Scarano E , Torrisi R , Shaked Y , Mancuso P , Goldhirsch A , Rocca A , Pietri E , Colleoni M : Metronomic cyclophosphamide and capecitabine combined with Bevacizumab in advanced breast cancer .", "label": "", "metadata": {}, "score": "74.06923"}
{"text": "A total of 122 children were randomized to AL and 124 to DP , resulting in 412 and 425 treatments , respectively .Most adverse events were rare , with only cough , diarrhoea , vomiting , and anaemia occurring in more than 1 % of treatments .", "label": "", "metadata": {}, "score": "74.12456"}
{"text": "Haemoglobin measurements were repeated on day 28 or earlier if severe anaemia was suspected .At each follow - up visit , adverse events were identified by evaluating for any new or worsening symptoms , physical exam findings , or haemoglobin values , as compared to the day 0 baseline assessment .", "label": "", "metadata": {}, "score": "74.13562"}
{"text": "Bosi E , Camisasca RP , Collober C , Rochotte E , Garber AJ : Effects of vildagliptin on glucose control over 24 weeks in patients with type 2 diabetes inadequately controlled with metformin .", "label": "", "metadata": {}, "score": "74.2139"}
{"text": "Both AL and DP were safe and well tolerated for the treatment of uncomplicated malaria in young HIV - infected and uninfected children .Trial Registration .", "label": "", "metadata": {}, "score": "74.305084"}
{"text": "Among HIV - uninfected patients , there was no association between concomitant use of TS and the risk of diarrhoea or vomiting for both treatment arms .", "label": "", "metadata": {}, "score": "74.32492"}
{"text": "View Article .J Clin Oncol 2008 , 28 : 4672 - 4678 .View Article .Scartozzi M , Galizia E , Chiorrini S , Giampieri R , Berardi R , Pierantoni C , Cascinu S : Arterial hypertension correlates with clinical outcome in colorectal cancer patients treated with first - line bevacizumab .", "label": "", "metadata": {}, "score": "74.41008"}
{"text": "All radiographic images were reviewed centrally by an independent radiologist ( AMP ) .Activity was assessed according to RECIST version 1.0 ( CT or MRI ) at baseline and every 3 months .", "label": "", "metadata": {}, "score": "74.45647"}
{"text": "Able to understand and comply with the requirements of the protocol .Exclusion Criteria : .The patient is receiving concomitant radiotherapy , chemotherapy , other antineoplastic therapy , or investigational therapy ( other than the investigational therapy under study ) .", "label": "", "metadata": {}, "score": "74.50767"}
{"text": "ANN INTERN MED 2003;139:933 - 949 .Anesthetic Considerations for Bariatric Surgery Ogunnaike et al .Anesth .Analg .FULL TEXT .Effects of Obesity Surgery on Non - Insulin - Dependent Diabetes Mellitus Greenway et al .", "label": "", "metadata": {}, "score": "74.522415"}
{"text": "Second , most anti - malarial clinical trials are limited to single episodes of uncomplicated malaria in the same patient , which precludes the ability to analyse the effect of repeated treatments .", "label": "", "metadata": {}, "score": "74.618"}
{"text": "Based on these results , Advancis expected to file a NDA for once - daily Amoxicillin by late 2006 or early 2007 .Enzo Biochem issued positive long term results from a phase I trial , initiated in January of 2001 , of HGTV43 for the treatment of HIV .", "label": "", "metadata": {}, "score": "74.64311"}
{"text": "Three hundred twenty - eight patients completed 2 years of double - blind treatment ( 91 [ 43 % ] received placebo , 120 [ 56 % ] received 60 mg of orlistat , and 117 [ 56 % ] received 120 mg of orlistat ) .", "label": "", "metadata": {}, "score": "74.6696"}
{"text": "A similar assessment , including physical examination , was repeated at the end of 52 and 104 weeks .Interim brief physician visits were scheduled at weeks 1 , 2 , 8 , 16 , 24 , 32 , 44 , 60 , 76 , and 92 .", "label": "", "metadata": {}, "score": "74.74515"}
{"text": "Roth DE , Mahmud AA , Raqib R , Akhtar E , Black RE , Baqui AH .Pharmacokinetics of High - Dose Weekly Oral Vitamin D3 Supplementation during the Third Trimester of Pregnancy in Dhaka , Bangladesh .", "label": "", "metadata": {}, "score": "74.755325"}
{"text": "All adverse events were recorded , regardless of their relationship to treatment .To ensure consistency in identifying GI events related to orlistat treatment , a dictionary of standard terms was developed to describe defecation patterns .", "label": "", "metadata": {}, "score": "74.75822"}
{"text": "CONCLUSIONS : Soybean / MCT / olive / fish emulsion was safe and well tolerated over 4 weeks and leads to positive change in fatty acids profile .", "label": "", "metadata": {}, "score": "74.78334"}
{"text": "Foster GD , Wadden TA , Vogt RA , Brewer G. What is a reasonable weight loss ? patients ' expectations and evaluations of obesity treatment outcomes .", "label": "", "metadata": {}, "score": "74.80525"}
{"text": "Although ACT has been shown to be highly efficacious , concerns remain about its safety and tolerability , especially in certain patient populations , such as young children and those with co - morbidities such as HIV .", "label": "", "metadata": {}, "score": "74.94766"}
{"text": "Abstract .Background .Artemisinin combination therapy has become the standard of care for uncomplicated malaria in most of Africa .However , there is limited data on the safety and tolerability of these drugs , especially in young children and patients co - infected with HIV .", "label": "", "metadata": {}, "score": "75.04057"}
{"text": "Non - treatment related risk factors for diarrhoea and vomiting over 28 days of follow - up stratified by treatment group were identified using multivariate analysis ( Table 3 ) .", "label": "", "metadata": {}, "score": "75.05281"}
{"text": "FREE FULL TEXT .Kanders BS , Blackburn GL .Health consequences of therapeutic weight loss : reducing primary risk factors .In : Wadden TA , van Itallie TB , eds .", "label": "", "metadata": {}, "score": "75.1956"}
{"text": "Finally , this study was not powered to specifically test for hypothesis of differences in the risk of adverse events between the various subgroups .Therefore , the possibility of type II errors can not be ruled out , especially in those subgroups with small samples sizes such as HIV - infected children taking ARVs .", "label": "", "metadata": {}, "score": "75.37404"}
{"text": "All study participants were given a long - lasting insecticide - treated bed net ( ITN ) at enrollment .Daily TS prophylaxis was given to all HIV - infected and HIV - exposed participants , as per national guidelines .", "label": "", "metadata": {}, "score": "75.4521"}
{"text": "In a randomized phase 2 trial , the combination of bevacizumab and octreotide had a greater efficacy than interferon \u03b12 and octreotide [ 10 ] .", "label": "", "metadata": {}, "score": "75.508194"}
{"text": "No association was found between rs699947 polymorphism and proteinuria .No association between rs1570360 polymorphism and either hypertension or proteinuria was observed .Rs699947 and rs1570360 polymorphisms both failed to be associated with progression - free survival ( data not shown ) .", "label": "", "metadata": {}, "score": "75.528534"}
{"text": "Aschner P , Kipnes MS , Lunceford JK , Sanchez M , Mickel C , Williams - Herman DE , the Sitagliptin Study 021 Group : Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes .", "label": "", "metadata": {}, "score": "75.77669"}
{"text": "Statistical Analysis .Analyses were performed with the \" intention - to - treat \" method .Predefined primary end - points were the differences in fatigue scores between two hours after intervention , and one day after intervention .", "label": "", "metadata": {}, "score": "75.82068"}
{"text": "One weakness of the current trial is the preplanned stop of capecitabine and bevacizumab at the ninth month .It is unclear whether that could have influenced the clinical results , since a significant proportion of patients received bevacizumab until disease progression .", "label": "", "metadata": {}, "score": "75.84914"}
{"text": "Active and passive surveillance for adverse events .On the day that treatment was initiated ( day 0 ) , a baseline assessment was conducted , consisting of a standardized history and physical examination and haemoglobin measurement using a portable spectrophotometer ( Hemocue , Angelholm Sweden ) .", "label": "", "metadata": {}, "score": "75.882904"}
{"text": "Assessment of Adverse Events .During intervention and at both post - intervention assessments , study nurses assessed adverse events by asking open - ended questions .", "label": "", "metadata": {}, "score": "75.918785"}
{"text": "Talisuna AO , Staedke SG , D'Alessandro U : Pharmacovigilance of antimalarial treatment in Africa : Is it possible ?Malar J 2006 , 5 : 50 .", "label": "", "metadata": {}, "score": "76.26564"}
{"text": "Oxidative stress is thought to underlie fatigue to some extent ; serum markers of oxidative stress are associated with symptoms of chronic fatigue syndrome , including asthenia after physical activity and arthralgias [ 3 ] .", "label": "", "metadata": {}, "score": "76.29272"}
{"text": "Women were excluded if they were pregnant , lactating , or of childbearing potential and not taking adequate contraceptive measures .There was no overlap between the subjects who participated in this trial and subjects in any other clinical trial of orlistat .", "label": "", "metadata": {}, "score": "76.47043"}
{"text": "View Article PubMed .Dooley KE , Flexner C , Andrade AS : Drug interactions involving combination antiretroviral therapy and other anti - infective agents : Repercussions for resource - limited countries .", "label": "", "metadata": {}, "score": "76.514534"}
{"text": "In a study of healthy subjects the PI lopinavir / ritonavir increased the lumefantrine area under the curve ( AUC ) by 193 % , though no significant toxicities were reported [ 26 ] .", "label": "", "metadata": {}, "score": "76.5506"}
{"text": "22 The last observation carried forward technique was employed for 1- and 2-year analyses , as recommended in the Consolidated Standard of Reporting Trials ( CONSORT ) statement .", "label": "", "metadata": {}, "score": "76.605034"}
{"text": "Simon R : Optimal two - stage designs for phase II clinical trials .Control Clin Trials 1989 , 10 : 1 - 10 .10.1016/0197 - 2456(89)90015 - 9 View Article PubMed .", "label": "", "metadata": {}, "score": "76.620636"}
{"text": "Mechanism of conjugated linoleic acid and vaccenic acid formation in human faecal suspensions and pure cultures of intestinal bacteria McIntosh et al .Microbiology 2009;155:285 - 294 .", "label": "", "metadata": {}, "score": "76.63783"}
{"text": "Fatty acid pattern in red blood cell phospholipids and plasma lipoproteins , serum Vitamin E , Interleukin ( IL)-6 , and soluble tumour necrosis ( s - TNF)-receptor(R)II were also evaluated .", "label": "", "metadata": {}, "score": "76.77462"}
{"text": "Review : Pharmacotherapy as part of a weight management programme : a UK perspective Barnett British Journal of Diabetes & Vascular Disease 2007;7:268 - 277 .", "label": "", "metadata": {}, "score": "76.88208"}
{"text": "It is a chronic disorder , like hypertension ; consequently , weight loss must be achieved and maintained for a prolonged period to meet both physician and patient goals .", "label": "", "metadata": {}, "score": "77.056244"}
{"text": "At 48 months , 4 subjects were available and 3 out of the 4 had antisense RNA present and at month 60 it was present in 1 out of the 3 subjects .", "label": "", "metadata": {}, "score": "77.32901"}
{"text": "Baseline VEGF values , dichotomized at the median value , failed to be associated with progression - free survival ( HR 1.31 ; 95 % CI , 0.61 - 2.79 ) .", "label": "", "metadata": {}, "score": "77.334076"}
{"text": "Bates DW , Schmitt W , Buchwald D , Ware NC , Lee J , Thoyer E , Kornish RJ , Komaroff AL : Prevalence of fatigue and chronic fatigue syndrome in a primary care practice .", "label": "", "metadata": {}, "score": "77.34383"}
{"text": "View Article PubMed .German P , Parikh S , Lawrence J , Dorsey G , Rosenthal PJ , Havlir D , Charlebois E , Hanpithakpong W , Lindegardh N , Aweeka FT : Lopinavir / ritonavir affects pharmacokinetic exposure of artemether / lumefantrine in HIV - uninfected healthy volunteers .", "label": "", "metadata": {}, "score": "77.40207"}
{"text": "Metronomic administration of chemotherapy inhibits angiogenesis and vasculogenesis by continuously exposing the more slowly proliferating tumor endothelial cells to the damaging action of the cytotoxic therapy [ 16 ] .", "label": "", "metadata": {}, "score": "77.515335"}
{"text": "Change in fatigue scores between the trial and placebo group were analyzed using ANCOVA within each group .Statistical analyses were performed using SPSS , version 16.02 ( SPSS , Chicago , IL , USA ) .", "label": "", "metadata": {}, "score": "77.645355"}
{"text": "ABSTRACT .Allison DB , Cappelleri JC , Carpenter KM .Design and analysis of obesity treatment and prevention trials .In : Dalton S , ed .", "label": "", "metadata": {}, "score": "77.87429"}
{"text": "The World Health Organization ( WHO ) has established guidelines for evaluating the efficacy of anti - malarial drugs , but no similar guidelines exist for safety monitoring [ 8 - 10 ] .", "label": "", "metadata": {}, "score": "78.012726"}
{"text": "( Table 1 ) .When follow - up was extended to 63 days , 492 ( 59 % ) patients had recurrent malaria , with no difference observed between those treated with AL and those treated with DP .", "label": "", "metadata": {}, "score": "78.120255"}
{"text": "Authors ' contributions .SYS developed the study protocol and clinical trial procedures , contributed to the quality control and data cleaning / analysis / interpretation and wrote the first draft of the paper .", "label": "", "metadata": {}, "score": "78.23845"}
{"text": "15 - 16 A drug that alters the absorption of ingested nutrients can potentially induce negative energy balance , assuming incomplete dietary compensation .Orlistat reduces dietary fat absorption in a dose - dependent fashion , with a maximal inhibition of 30 % fat absorption at a dosage of 120 mg 3 times a day ( TID ) .", "label": "", "metadata": {}, "score": "78.54033"}
{"text": "Data were double entered into Microsoft Access and analysed using Stata version 10 ( Stata , College Station , TX , USA ) .Data were evaluated with an intention - to - treat analysis including all episodes of uncomplicated malaria in children who were assigned treatment with study drugs through September 2008 .", "label": "", "metadata": {}, "score": "78.86505"}
{"text": "View Article .Skapinakis P , Lewis G , Meltzer H : Clarifying the relationship between unexplained chronic fatigue and psychiatric morbidity : results from a community survey in Great Britain .", "label": "", "metadata": {}, "score": "79.07033"}
{"text": "Guidelines for the treatment of uncomplicated malaria in Africa have recently undergone a paradigm shift away from inexpensive monotherapies , such as chloroquine and sulphadoxine - pyrimethamine , to artemisinin - based combination therapies ( ACT ) .", "label": "", "metadata": {}, "score": "79.10835"}
{"text": "Additionally , most anti - malarial safety data come from clinical trials evaluating single episodes of malaria , while in practice African children are often treated repeatedly for recurring episodes of malaria over a relatively short period of time .", "label": "", "metadata": {}, "score": "79.18788"}
{"text": "Eckel RH , Krauss RM for the AHA Nutrition Committee .American Heart Association call to action : obesity as a major risk factor for coronary heart disease .", "label": "", "metadata": {}, "score": "79.25374"}
{"text": "The significance of treatment differences in the primary efficacy parameters was tested using analysis of variance models that took into account centers , strata , and randomization groups , or , in the case of empty strata , an analysis of covariance model .", "label": "", "metadata": {}, "score": "79.33559"}
{"text": "The dropped participants completed two outcome measurements ( baseline and two hours after intervention ) , but did not complete the third measurement ( after 24 hour time point ) the next day .", "label": "", "metadata": {}, "score": "79.45787"}
{"text": "A review of AL safety and tolerability in 1,869 patients ( 33 % children ) from Asia reported gastro - intestinal complaints ( nausea , vomiting , and diarrhoea ) , headache , and dizziness as the most commonly reported adverse events [ 16 ] .", "label": "", "metadata": {}, "score": "79.48596"}
{"text": "Kerbel RS , Kamen BA : The anti - angiogenic basis of metronomic chemotherapy .Nat Rev Cancer 2004 , 4 : 423 - 436 .", "label": "", "metadata": {}, "score": "79.52246"}
{"text": "Baseline characteristics of all episodes of uncomplicated malaria treated with study drugs .Comparison of risks for clinical adverse events between study drugs .Any adverse event due to cough , diarrhoea , or vomiting occurred in 296 of 412 ( 72 % ) treatments with AL and 313 of 425 ( 74 % ) treatments with DP .", "label": "", "metadata": {}, "score": "79.57222"}
{"text": "A pre - determined list of 43 adverse events and standardized definitions was developed using the United States National Institutes of Health , Division of AIDS Table for Grading the Severity of Adult and Pediatric Adverse Events [ 14 ] .", "label": "", "metadata": {}, "score": "79.590805"}
{"text": "The solution of the same number was administered to each participant by the study nurses .The participants and study nurses assessing the outcomes were blinded to the group assignment .", "label": "", "metadata": {}, "score": "79.61175"}
{"text": "Diagnosis and Treatment of Obesity in Adults : An Applied Evidence - Based Review Orzano and Scott J Am Board Fam Med 2004;17:359 - 369 .", "label": "", "metadata": {}, "score": "79.7525"}
{"text": "Risk factors for adverse events due to diarrhoea or vomiting within 28 days following therapy .Risk of adverse events due to anaemia and serious adverse events .", "label": "", "metadata": {}, "score": "79.82108"}
{"text": "We thank Ah - Ram Seo for her assistance in additional analysis .Competing interests .CHY is the chairperson of the Korean Association for Vitamin Research .", "label": "", "metadata": {}, "score": "79.82797"}
{"text": "When the patients were grouped according to the primary cancer site , a disease response was more frequently observed in those with pancreatic cancer ( 5/19 , 26.3 % ) than in those with non - pancreatic cancer ( 3/26 , 11.5 % ) .", "label": "", "metadata": {}, "score": "79.93152"}
{"text": "Sj\u00f6str\u00f6m L , Rissanen A , Andersen T for the European Multicentre Orlistat Study Group .Randomised placebo - controlled trial of orlistat for weight loss and prevention of weight regain in obese patients .", "label": "", "metadata": {}, "score": "79.99014"}
{"text": "Setting Seventeen primary care centers in the United States .Main Outcome Measures Changes in body weight and obesity - related disease risk factors .Orlistat produced greater improvements than placebo in serum lipid levels and blood pressure and was well tolerated , although treatment resulted in a higher incidence of gastrointestinal events .", "label": "", "metadata": {}, "score": "80.22022"}
{"text": "J Med Chem 50 : 2297 -2300 , 2007 .Clin Ther 30 : 499 -512 , 2008 .Lee B , Shi L , Kassel DB , Asakawa T , Takeuchi K , Christopher RJ : Pharmacokinetic , pharmacodynamic , and efficacy profiles of alogliptin , a novel inhibitor of dipeptidyl peptidase-4 , in rats , dogs , and monkeys .", "label": "", "metadata": {}, "score": "80.251045"}
{"text": "The concomitant use of ARVs and ACT is of greater concern because drug toxicities and the potential for drug interactions [ 25 ] .Artemether is metabolized via CYP3A4 to the more active compound dihydroartemisinin .", "label": "", "metadata": {}, "score": "80.500916"}
{"text": "Alogliptin is a novel , high - affinity , high - specificity DPP-4 inhibitor that produces rapid and sustained DPP-4 inhibition and significantly reduces postprandial plasma glucose concentrations in patients with type 2 diabetes ( 2 , 3 ) .", "label": "", "metadata": {}, "score": "80.547745"}
{"text": "Patients .Previous treatments with a somatostatin analogue and/or radionuclide therapy were permitted .This study was first approved by the Ethic Committee of the Azienda Ospedaliera San Luigi , Orbassano , Italy .", "label": "", "metadata": {}, "score": "80.6899"}
{"text": "Compared to HIV - uninfected not taking TS , concomitant use of TS and ARVs among HIV - infected patients was not associated with an increased risk of diarrhoea or vomiting in either treatment arm .", "label": "", "metadata": {}, "score": "80.90529"}
{"text": "26 Therefore , there is clearly a need for effective and safe therapeutic options that are accessible to primary care physicians with limited ancillary resources to effect dietary and lifestyle changes .", "label": "", "metadata": {}, "score": "80.91855"}
{"text": "View Article PubMed .Omari AA , Gamble C , Garner P : Artemether - lumefantrine ( six - dose regimen ) for treating uncomplicated falciparum malaria .", "label": "", "metadata": {}, "score": "81.01308"}
{"text": "The patient has the capability of understanding the informed consent document and has signed the informed consent document .Sexually active patients ( male and female ) must use medically acceptable methods of contraception during the course of the study .", "label": "", "metadata": {}, "score": "81.1035"}
{"text": "Definitions of adverse events .Participants randomized to treatment with study medications were assessed for adverse events beginning after their first dose of study drug .", "label": "", "metadata": {}, "score": "81.39871"}
{"text": "Obesity Yanovski and Yanovski NEJM 2002;346:591 - 602 . FULL TEXT .Evidence - Based Nutrition Principles and Recommendations for the Treatment and Prevention of Diabetes and Related Complications Franz et al .", "label": "", "metadata": {}, "score": "81.70596"}
{"text": "As the use of ACT is scaled up in Africa , continued evaluation of the safety and tolerability of these drugs in diverse patient populations is essential .", "label": "", "metadata": {}, "score": "82.10262"}
{"text": "Obesity is one of the most common chronic conditions seen by primary care physicians ; these physicians treat most obesity in the United States .However , poor long - term success in weight management , time constraints , and the absence of safe and effective drug therapy 13 - 14 prevent primary care physicians from being even more involved in managing obesity .", "label": "", "metadata": {}, "score": "82.14864"}
{"text": "FREE FULL TEXT .National Heart , Lung , and Blood Institute .Clinical Guidelines on the Identification , Evaluation , and Treatment of Overweight and Obesity in Adults .", "label": "", "metadata": {}, "score": "82.22639"}
{"text": "View Article PubMed .Dorsey G , Staedke S , Clark TD , Njama - Meya D , Nzarubara B , Maiteki - Sebuguzi C , Dokomajilar C , Kamya MR , Rosenthal PJ : Combination therapy for uncomplicated falciparum malaria in Ugandan children : A randomized trial .", "label": "", "metadata": {}, "score": "82.689964"}
{"text": "ASSESSMENTS .The initial screening assessment consisted of a medical history and physical examination , an electrocardiogram , and measurement of laboratory parameters and body weight .", "label": "", "metadata": {}, "score": "82.919846"}
{"text": "Nutr .Clinical Implications of Obesity With Specific Focus on Cardiovascular Disease : A Statement for Professionals From the American Heart Association Council on Nutrition , Physical Activity , and Metabolism : Endorsed by the American College of Cardiology Foundation Klein et al .", "label": "", "metadata": {}, "score": "82.968124"}
{"text": "There is a strong rationale for combining metronomic chemotherapy with antiangiogenic drugs [ 19 ] .Prior preclinical metronomic chemotherapy studies have shown that the combination of antiangiogenic drugs with metronomic chemotherapy can increase antitumor efficacy compared to either agent alone [ 19 , 20 ] .", "label": "", "metadata": {}, "score": "83.143585"}
{"text": "Yao JC , Phan A , Hoff PM , Chen HX , Charnsangavej C , Yeung SC , Ajani JA : Targeting vascular endothelial growth factor in advanced carcinoid tumor : a random assignment phase II study of depot octreotide with bevacizumab and pegylated interferon alpha-2b .", "label": "", "metadata": {}, "score": "83.18562"}
{"text": "Results .Partial response was obtained in 8 patients ( 17.8 % , 95 % confidence interval [ CI ] , 6.4%-28.2 % ) ; tumor response was more frequent in pancreatic than in non - pancreatic malignancies .", "label": "", "metadata": {}, "score": "83.33827"}
{"text": "The patient is pregnant or breastfeeding .The patient is unable or unwilling to abide by the study protocol or cooperate fully with the investigator or designee .", "label": "", "metadata": {}, "score": "83.51912"}
{"text": "Study Phase .Phase 1 .Study Design ICMJE .Endpoint Classification : Safety / Efficacy Study Intervention Model : Single Group Assignment Masking : Open Label Primary Purpose : Treatment .", "label": "", "metadata": {}, "score": "83.53541"}
{"text": "The clinical trial registration of this trial is ClinicalTrials.gov NCT00633581 .Setting and Participants .The study was designed to include 150 volunteers ( Korean , office workers or salespeople ) .", "label": "", "metadata": {}, "score": "83.55649"}
{"text": "Participants were censored on the day prior to repeat therapy with study drugs to remove the potential confounding effect of recurrent malaria , which can mimic adverse events [ 15 ] .", "label": "", "metadata": {}, "score": "83.6597"}
{"text": "Adverse events due to cough were not included in this analysis because this adverse event was unlikely to be causally related to anti - malarial therapy based on previous reports [ 3 - 7 ] .", "label": "", "metadata": {}, "score": "83.68416"}
{"text": "Nucleoside reverse transcriptase inhibitors ( NRTIs ) are not thought to have clinical significant interactions with commonly used ACTs [ 25 ] .Prior studies have found an association between amodiaquine - based anti - malarial therapy and neutropaenia in HIV - infected children [ 27 ] .", "label": "", "metadata": {}, "score": "83.75699"}
{"text": "The XELBEVOCT trial , a single - arm multicenter Italian phase 2 study , was designed to test the activity of the association of metronomic capecitabine , bevacizumab , and octreotide in the treatment of advanced / metastatic WMD - NEN .", "label": "", "metadata": {}, "score": "83.88905"}
{"text": "At 4 points during the second year , they were given weight management and diet pamphlets designed to assist in weight maintenance .The written materials were part of the Live for Life program ( Johnson & Johnson Health Management Inc , New Brunswick , NJ ) .", "label": "", "metadata": {}, "score": "84.04284"}
{"text": "Financial support for completion of this study and for data analysis was provided by Takeda Global Research & Development Center , Deerfield , Illinois .This study was presented at the 68th Annual Scientific Sessions of the American Diabetes Association , San Francisco , CA , 6 - 10 June 2008 , and at the 44th European Association for the Study for Diabetes Annual Meeting , Rome , Italy , 7 - 11 September 2008 .", "label": "", "metadata": {}, "score": "84.06607"}
{"text": "Mantovani G , Maccio A , Madeddu C , Mura L , Massa E , Gramignano G , Lusso MR , Murgia V , Camboni P , Ferreli L : Reactive oxygen species , antioxidant mechanisms and serum cytokine levels in cancer patients : impact of an antioxidant treatment .", "label": "", "metadata": {}, "score": "84.31518"}
{"text": "View Article PubMed .Fanello CI , Karema C , van Doren W , Van Overmeir C , Ngamije D , D'Alessandro U : A randomised trial to assess the safety and efficacy of artemether - lumefantrine ( Coartem ) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwanda .", "label": "", "metadata": {}, "score": "84.529015"}
{"text": "Centro Oncologico Ematologico Subalpino COES , Azienda Ospedaliera Molinette .References .Bosman FT , Carneiro F , Hruban RH , Theise ND : Tumors of the Digestive System .", "label": "", "metadata": {}, "score": "84.65579"}
{"text": "View Article PubMed .Myint HY , Ashley EA , Day NP , Nosten F , White NJ : Efficacy and safety of dihydroartemisinin - piperaquine .", "label": "", "metadata": {}, "score": "84.6677"}
{"text": "Transport Pharmaceuticals announced positive results from a phase IIb trial of device - enhanced acyclovir for the treatment of herpes labialis .This multi - center , randomized , double blind , placebo - controlled , clinic initiated , proof - of - concept trial enrolled 200 non - immunocompromised subjects , aged 18 - 75 years , with histories of recurrent cold sore outbreaks ( 3 or more annually ) .", "label": "", "metadata": {}, "score": "84.66825"}
{"text": "Haemolysis following treatment with DP in a child with G6PD deficiency has been described in a prior study from Laos [ 23 ] .However , it is unclear whether haemolytic anaemia is causally associated with DP or just a consequence of G6PD deficiency alone [ 23 ] .", "label": "", "metadata": {}, "score": "84.68614"}
{"text": "Acknowledgements .This work was supported in part by a research grant from Roche SpA and by \" MEMORIAL AMICI di MARCO TRECCANI \" .Competing interest .", "label": "", "metadata": {}, "score": "84.90315"}
{"text": "View Article PubMed .Modlin IM , Pavel M , Kidd M , Gustafsson BI : Review article : somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine ( carcinoid ) tumours .", "label": "", "metadata": {}, "score": "84.97957"}
{"text": "Table 3 shows body weight changes during the placebo lead - in period and during the 2 years of double - blind treatment for both the ITT population and the subjects who completed the 2 years of the study .", "label": "", "metadata": {}, "score": "85.31165"}
{"text": "OBESITY IS a chronic medical disorder affecting roughly one third of the population of the United States and is associated with increased morbidity and mortality . 1 - 5 Considerable evidence suggests that weight loss of 5 % to 10 % of initial body weight substantially improves the health of obese patients .", "label": "", "metadata": {}, "score": "85.327354"}
{"text": "Trial registration .Keywords .Bevacizumab Pancreatic endocrine tumor Capecitabine Octreotide .Background .Neuroendocrine neoplasms constitute a highly heterogeneous spectrum of tumors with a variety of biological and clinical behaviors .", "label": "", "metadata": {}, "score": "85.55014"}
{"text": "Safety findings were summarized with descriptive statistics .RESULTS- .Baseline characteristics were similar among treatment groups .Participants had a mean \u00b1 SD age of 53.4 \u00b1 11.1 years and baseline A1C 7.9 \u00b1 0.08 % and were predominantly male ( 53.2 % ) and white ( 66.9 % ) .", "label": "", "metadata": {}, "score": "85.569336"}
{"text": "A blood sample taken during the anemic episode in the month prior to his death was direct Coombs test positive , indicative of immune - mediated haemolytic anaemia .", "label": "", "metadata": {}, "score": "85.57652"}
{"text": "This study also provides data on the safety and tolerability of ACT in unique patient populations including those taking TS prophylaxis and HIV - infected patients taking ARVs .", "label": "", "metadata": {}, "score": "85.85378"}
{"text": "At the last follow - up evaluation in June 2011 , 35 ( 77.8 % ) patients showed disease progression and 14 ( 31.1 % ) had died .", "label": "", "metadata": {}, "score": "85.91525"}
{"text": "View Article PubMed .Maiteki - Sebuguzi C , Jagannathan P , Yau VM , Clark TD , Njama - Meya D , Nzarubara B , Talisuna AO , Kamya MR , Rosenthal PJ , Dorsey G , Staedke SG : Safety and tolerability of combination antimalarial therapies for uncomplicated falciparum malaria in Ugandan children .", "label": "", "metadata": {}, "score": "86.17902"}
{"text": "The present study was undertaken to fill this gap in current knowledge .Orlistat is a selective and potent inhibitor of gastrointestinal ( GI ) lipases involved in triglyceride hydrolysis , which restricts the absorption of triglycerides from the GI tract .", "label": "", "metadata": {}, "score": "86.28797"}
{"text": "10.1007/s00428 - 011 - 1060 - 7 View Article PubMed .Fazio N , Cinieri S , Lorizzo K , Squadroni M , Orlando L , Spada F , Macello E , Bodei L , Paganelli G , Delle Fave G , De Braud F : Biological targeted therapies in patients with advanced enteropancreatic neuroendocrine carcinomas .", "label": "", "metadata": {}, "score": "86.39021"}
{"text": "CHY contributed the development of the protocol , directed the conduct of the trial , and assisted with drafting the manuscript .GCJ assisted with acquisition of data and editing of the paper .", "label": "", "metadata": {}, "score": "86.61633"}
{"text": "A phase II trial of the Piemonte Oncology Network .BMC Cancer 2009 , 9 : 388 - 395 .10.1186/1471 - 2407 - 9 - 388 View Article PubMed Central PubMed .", "label": "", "metadata": {}, "score": "86.68147"}
{"text": "The study protocol was approved by the Uganda National Council of Science and Technology and the institutional review boards of the University of California , San Francisco , Makerere University , the University of Washington , and the Centers for Disease Control and Prevention .", "label": "", "metadata": {}, "score": "86.87279"}
{"text": "Department of Gastroenterology , Asan Medical Center , University of Ulsan , College of Medicine .Hana Primary Care Clinic .Yeom Primary Care Clinic .", "label": "", "metadata": {}, "score": "86.97462"}
{"text": "Discussion .Results from this longitudinal randomized clinical trial suggest that both AL and DP are safe for treating uncomplicated malaria in young HIV - infected and uninfected infants and children .", "label": "", "metadata": {}, "score": "87.016945"}
{"text": "View Article .Volante M , Righi L , Berruti A , Rindi G , Papotti M : The pathological diagnosis of neuroendocrine tumors : common questions and tentative answers .", "label": "", "metadata": {}, "score": "87.34092"}
{"text": "In particular none of the authors the past five years received reimbursements , fees , funding , or salary from an organization that may in any way gain or lose financially from the publication of this manuscript , either now or in the future .", "label": "", "metadata": {}, "score": "87.44089"}
{"text": "Dihydroartemisinin - piperaquine study drugs were provided free of charge by Holleypharm , China .The funders had no involvement in the study design , data collection , data analysis , data interpretation , in the writing of the manuscript , or in the decision to submit it for publication .", "label": "", "metadata": {}, "score": "87.648964"}
{"text": "View Article PubMed .Lancet 2005 , 365 : 1474 - 80 .View Article PubMed .Bukirwa H , Yeka A , Kamya MR , Talisuna A , Banek K , Bakyaita N , Rwakimari JB , Rosenthal PJ , Wabwire - Mangen F , Dorsey G , Staedke SG : Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda .", "label": "", "metadata": {}, "score": "88.093864"}
{"text": "The past medical history was investigated by research nurses and the principal investigator , a board - certified family physician , performed physical examination for the participants .", "label": "", "metadata": {}, "score": "88.22809"}
{"text": "Patient population and characteristics of study drug treatments .A total of 351 children were enrolled in the cohort study , of which 246 ( 70 % ) had at least one episode of uncomplicated malaria and were randomized to study drugs .", "label": "", "metadata": {}, "score": "88.34943"}
{"text": "Mice with a disorder resembling the type 1B form of Charcot - Marie - Tooth disease ( CMT ) benefited from treatment with either of two forms of oral curcumin , a component of the spice turmeric , according to researchers supported in part by MDA . all Addendum Article Book Review Case Report Comment Commentary Communication Concept Paper Conference Report Correction Creative Data Descriptor Discussion Editorial Erratum Essay Interesting Images Letter New Book Received Obituary Opinion Project Report Reply Retraction Review Short Note Technical Note .", "label": "", "metadata": {}, "score": "88.8724"}
{"text": "View Article PubMed .Karema C , Fanello CI , van Overmeir C , van Geertruyden JP , van Doren W , Ngamije D , D'Alessandro U : Safety and efficacy of dihydroartemisinin / piperaquine ( Artekin ) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan children .", "label": "", "metadata": {}, "score": "89.04543"}
{"text": "Based on these results , Vaxgen planned further development of this drug .Related Medical Areas .This information does not represent a Lupus Research Institute endorsement of any listed study .", "label": "", "metadata": {}, "score": "89.15419"}
{"text": "First there is limited data on the safety of these drugs in children under 12 months of age , an important population in Africa .Study participants initiated ACT therapy at four months of age and over 50 % of the treatments given for uncomplicated malaria were in children younger than 12 months .", "label": "", "metadata": {}, "score": "89.159035"}
{"text": "A longitudinal , randomized controlled trial was conducted in a cohort of HIV - infected and uninfected children aged 4 - 22 months in Tororo , Uganda .", "label": "", "metadata": {}, "score": "89.972885"}
{"text": "In short , the least squares mean is the expected value of the treatment means for a balanced design with all the covariates at their mean value .", "label": "", "metadata": {}, "score": "89.98089"}
{"text": "Results of a study comparing the efficacy AL and DP for the treatment of uncomplicated malaria using a longitudinal study design in a cohort of young children living in an area of very high malaria transmission intensity in Uganda were recently published [ 11 ] .", "label": "", "metadata": {}, "score": "89.998344"}
{"text": "Idebenone ( under the brand name Catena ) in July 2008 received conditional market approval in Canada for the treatment of Friedreich 's ataxia ( FA ) .", "label": "", "metadata": {}, "score": "90.46202"}
{"text": "Hypertension , however , has been associated with drug efficacy in breast cancer and colon cancer patients [ 11 , 12 ] , and proteinuria has been suggested as a potential marker of drug efficacy [ 13 ] .", "label": "", "metadata": {}, "score": "90.542854"}
{"text": "View Article PubMed .World Health Organization ( WHO ) : Susceptibility of Plasmodium falciparum to antimalarial drugs : Report on global monitoring 1996 - 2004 .", "label": "", "metadata": {}, "score": "90.82932"}
{"text": "24 However , all reported data are the actual observed values rather than derived data from carrying forward the last recorded values .The 2 statistic was used to test the significance of differences in proportions .", "label": "", "metadata": {}, "score": "90.94403"}
{"text": "View Article PubMed .Yeka A , Dorsey G , Kamya MR , Talisuna A , Lugemwa M , Rwakimari JB , Staedke SG , Rosenthal PJ , Wabwire - Mangen F , Bukirwa H : Artemether - lumefantrine versus dihydroartemisinin - piperaquine for treating uncomplicated malaria : A randomized trial to guide policy in Uganda .", "label": "", "metadata": {}, "score": "91.08583"}
{"text": "Mehta U , Durrheim D , Mabuza A , Blumberg L , Allen E , Barnes KI : Malaria pharmacovigilance in Africa : Lessons from a pilot project in Mpumalanga province , South Africa .", "label": "", "metadata": {}, "score": "91.92686"}
{"text": "Transport plans to conduct additional phase II trials in the next year .VaxGen reported positive results from a phase I trial of rPA102 , the company 's anthrax vaccine candidate .", "label": "", "metadata": {}, "score": "92.22194"}
{"text": "PubMed .Kamya MR , Yeka A , Bukirwa H , Lugemwa M , Rwakimari JB , Staedke SG , Talisuna AO , Greenhouse B , Nosten F , Rosenthal PJ , Wabwire - Mangen F , Dorsey G : Artemether - lumefantrine versus dihydroartemisinin - piperaquine for treatment of malaria : A randomized trial .", "label": "", "metadata": {}, "score": "92.22232"}
{"text": "View Article PubMed .Clin Infect Dis 2009 , 49 : 1629 - 37 .View Article PubMed .Okello PE , Van Bortel W , Byaruhanga AM , Correwyn A , Roelants P , Talisuna A , D'Alessandro U , Coosemans M : Variation in malaria transmission intensity in seven sites throughout Uganda .", "label": "", "metadata": {}, "score": "92.6646"}
{"text": "NeoMarkers , Fremont , CA , USA ) and synaptophysin ( clone Sy38 , diluted 1:100 , DakoCytomation , Glostrup , Denmark ) immunostaining .In addition , in all cases in which residual tumor tissue was available , immunohistochemical analyses of Ki-67 ( clone MIB-1 , diluted 1:150 , Dako ) and somatostatin receptor type 2A ( polyclonal , code SS-800 , diluted 1:3000 , BioTrend , Cologne , Germany ) were performed .", "label": "", "metadata": {}, "score": "92.71846"}
{"text": "View Article PubMed .Zongo I , Dorsey G , Rouamba N , Dokomajilar C , Sere Y , Rosenthal PJ , Ou\u00e9draogo JB : Randomized comparison of amodiaquine plus sulfadoxine - pyrimethamine , artemether - lumefantrine , and dihydroartemisinin - piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso .", "label": "", "metadata": {}, "score": "93.434555"}
{"text": "FULL TEXT .Extracts from \" \" Clinical Evidence \" \" : Obesity Arterburn and Noel BMJ 2001;322:1406 - 1409 .FULL TEXT .Targeted Advertising in Medical Journals Clemenson and Bowman Arch Fam Med 2000;9:791 - 791 .", "label": "", "metadata": {}, "score": "93.82939"}
{"text": "[ Time Frame : 12 weeks per participant ] [ Designated as safety issue : Yes ] .Current Secondary Outcome Measures ICMJE ( submitted : September 20 , 2011 ) .", "label": "", "metadata": {}, "score": "93.87007"}
{"text": "Levine M , Conry - Cantilena C , Wang Y , Welch RW , Washko PW , Dhariwal KR , Park JB , Lazarev A , Graumlich JF , King J , et al .", "label": "", "metadata": {}, "score": "94.133484"}
{"text": "Competing interests .The authors declare that they have no competing interests .Authors ' contributions .GD and EA supervised the clinical studies .SK and GD analysed the data .", "label": "", "metadata": {}, "score": "94.35521"}
{"text": "AB drafted the manuscript ; MPB and AF acquired the data and revising manuscript critically ; NF and LB assisted in data acquisition ; MV and MP performed the histological diagnoses ; AMP performed the extramural radiologic review .", "label": "", "metadata": {}, "score": "94.52519"}
{"text": "If you are presently under the care of a physician for lupus or other conditions , you should not disrupt your current program without discussing it with your doctor(s ) .", "label": "", "metadata": {}, "score": "94.98888"}
{"text": "[ Time Frame : 12 weeks per participant ] [ Designated as safety issue : No ] .Original Primary Outcome Measures ICMJE ( submitted : September 25 , 2009 ) .", "label": "", "metadata": {}, "score": "95.00212"}
{"text": "Acknowledgements .We thank the clinical study team and our administrative staff .We are grateful to the children who participated in this study , and to their parents and guardians .", "label": "", "metadata": {}, "score": "95.31181"}
{"text": "December 3 , 2007 .Transport reported positive results from a phase II trial of SoloVir for the treatment of Herpes labialis .This randomized , double blind , placebo - controlled trial , dubbed TPI - H-221 , enrolled two hundred and sixty subjects .", "label": "", "metadata": {}, "score": "95.495735"}
{"text": "PubMed .International Conference on Harmonisation ( ICH ) .ICH harmonised tripartite guideline : Clinical safety data management : Definitions and standards for expedited reporting E2A. Technical Document , ICH 1994 .", "label": "", "metadata": {}, "score": "95.72951"}
{"text": "10.1634/theoncologist.2011 - 0098 View Article PubMed Central PubMed .Bodei L , Pepe G , Paganelli G : Peptide receptor radionuclide therapy ( PRRT ) of neuroendocrine tumors with somatostatin analogues .", "label": "", "metadata": {}, "score": "95.92262"}
{"text": "Subjects who presented with fever had blood obtained by fingerprick for a thick blood smear .If the thick blood smear was positive , the patient was diagnosed with malaria .", "label": "", "metadata": {}, "score": "95.99431"}
{"text": "New York , NY : Guilford Press ; 1992:213 - 230 .Williamson DF , Pamuk E , Thus M , Flanders D , Byers T , Heath C. Prospective study of intentional weight loss and mortality in never - smoking US white women aged 40 - 64 years .", "label": "", "metadata": {}, "score": "96.17463"}
{"text": "Design .This study was a double - blind , random allocated , placebo - controlled trial conducted at two companies in the Republic of Korea .", "label": "", "metadata": {}, "score": "96.41858"}
{"text": "Other tumors were recruited for analysis but analyzed separately .The distribution of PFS and OS was estimated using the Kaplan - Meier method .The median PFS and OS in each stratum was calculated with 95 % confidence intervals .", "label": "", "metadata": {}, "score": "96.69104"}
{"text": "PubMed .Trop Med Int Health 2006 , 11 : 1157 - 65 .View Article PubMed .Tarning J , Ashley EA , Lindegardh N , Stepniewska K , Phaiphun L , Day NP , McGready R , Ashton M , Nosten F , White NJ : Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin - piperaquine in patients with Plasmodium falciparum malaria in Thailand .", "label": "", "metadata": {}, "score": "97.01999"}
{"text": "Authors ' Affiliations .Department of Family Medicine , Dongguk University Ilsan Hospital .Department of Medicine , Dongguk University .Health Promotion Center , Seoul National University Bundang Hospital .", "label": "", "metadata": {}, "score": "97.06872"}
{"text": "HYA generated the random allocation table , contributed to the quality control and data analysis / interpretation , and has been involved in revising the manuscript critically .", "label": "", "metadata": {}, "score": "97.39194"}
{"text": "Enzo is further investigating HGTV43 in phase I / II trials at this time .Tibotec Pharmaceuticals released positive results from a phase IIb trial of TMC125 for the treatment of HIV .", "label": "", "metadata": {}, "score": "97.63501"}
{"text": "Written informed consent was obtained from all patients before starting treatment .Histology and biochemical analyses .The histological diagnoses performed at each center were centrally reviewed by two experienced pathologists ( MV , MP ) .", "label": "", "metadata": {}, "score": "97.867805"}
{"text": "Chicago / Turabian Style .Roth , Daniel E. ; Mahmud , Abdullah A. ; Raqib , Rubhana ; Akhtar , Evana ; Black , Robert E. ; Baqui , Abdullah H. 2013 . \"", "label": "", "metadata": {}, "score": "99.34965"}
{"text": "Istituto Europeo di Oncologia IEO , NET study group .Oncologia Medica , Dipartimento di Scienze Cliniche e Biologiche , Universit\u00e0 di Torino , AOU .", "label": "", "metadata": {}, "score": "99.53062"}
{"text": "LD contributed to trial conception and design .All authors have given their approval of the final version of the manuscript .Authors ' Affiliations .", "label": "", "metadata": {}, "score": "99.58945"}
{"text": "There are no non - financial competing interests ( political , personal , religious , ideological , academic , intellectual , commercial or any other ) to declare in relation to this manuscript .", "label": "", "metadata": {}, "score": "99.59682"}
{"text": "Gender .Both .Ages .18 Years and older .Accepts Healthy Volunteers .No .Contacts ICMJE .Contact information is only displayed when the study is recruiting subjects Abstract .", "label": "", "metadata": {}, "score": "100.005646"}
{"text": "Only contact the listed numbers .The Lupus Research Institute does not have any jurisdiction over or further involvement with these studies , other than to make people aware that they are being conducted .", "label": "", "metadata": {}, "score": "100.32783"}
{"text": "Pathology and Genetics 2004 .Lyon : IARC Press ; 2004 .Lancet Oncol 2008 , 9 ( 1 ) : 61 - 72 .10.1016/S1470 - 2045(07)70410 - 2 View Article PubMed .", "label": "", "metadata": {}, "score": "100.668106"}
{"text": "The protocol was approved by the institutional review board at each center and conducted in accordance with the revised Declaration of Helsinki .STUDY DESIGN .", "label": "", "metadata": {}, "score": "102.5105"}
{"text": "View Article .Ataka S , Tanaka M , Nozaki S , Mizuma H , Mizuno K , Tahara T , Sugino T , Shirai T , Kajimoto Y , Kuratsune H , et al .", "label": "", "metadata": {}, "score": "103.92005"}
{"text": "N Engl J Med 2011 , 10;364 ( 6 ) : 501 - 513 .View Article .N Engl J Med 2011 , 10;364 ( 6 ) : 514 - 523 .", "label": "", "metadata": {}, "score": "103.96591"}
{"text": "10.1200/JCO.2008.17.4789 View Article PubMed .J Clin Oncol 2011 , 1;29 ( 7 ) : 934 - 943 .View Article .Virchows Arch 2006 , 449 ( 4 ) : 395 - 401 .", "label": "", "metadata": {}, "score": "104.85452"}
{"text": "Results from a study conducted in Australia show that a nighttime respiratory problem called obstructive sleep apnea occurs more frequently in people with Friedreich 's ataxia ( FA ) than in the general population .", "label": "", "metadata": {}, "score": "106.75201"}
{"text": "Dipartimento \" Ser\u00e0gnoli \" di Scienze Ematologiche ed Oncologiche , Universit\u00e0 di Bologna .Oncologia Medica , I.R.C.C.S. Ospedale Casa Sollievo della Sofferenza .Laboratorio di Farmacologia Clinica e Farmacogenetica , Dipartimento di Malattie Infettive , Universit\u00e0 di Torino .", "label": "", "metadata": {}, "score": "108.39665"}
{"text": "Eligibility Criteria ICMJE .Inclusion Criteria : .The patient has a resectable tumor or cyst arising from the pancreatic exocrine gland ( pancreatic ductal adenocarcinoma , intraductal papillary mucinous neoplasm of the pancreas , or mucinous cystic neoplasm of the pancreas ) and is undergoing surgical resection of the neoplasm .", "label": "", "metadata": {}, "score": "109.440125"}
{"text": "Pathology and Genetics .Lyon : IARC Press ; 2010 .Travis WD , Brambilla E , Muller - Hermelink HK , Harris CC : Tumours of the Lung , Pleura , Thymus and Heart .", "label": "", "metadata": {}, "score": "109.451035"}
{"text": "Less is known about the metabolism of piperaquine .There are three main classes of ARVs : protease inhibitors ( PIs ) , non - nucleoside reverse transcriptase inhibitors ( NNRTIs ) , and nucleoside reverse transcriptase inhibitors ( NRTIs ) .", "label": "", "metadata": {}, "score": "109.7579"}
{"text": "None of the authors hold or are currently applying for any patents relating to the content of the manuscript ; have you received reimbursements , fees , funding , or salary from an organization that holds or has applied for patents relating to the content of the manuscript .", "label": "", "metadata": {}, "score": "110.40848"}
{"text": "The costs of publication of this article were defrayed in part by the payment of page charges .This article must therefore be hereby marked \" advertisement \" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact .", "label": "", "metadata": {}, "score": "111.84437"}
{"text": "Authors ' Affiliations .Oregon Health and Science University .Department of Epidemiology , University of California .Makerere University - University of California San Francisco Research Collaboration .", "label": "", "metadata": {}, "score": "111.93556"}
{"text": "Study site and subjects .This study was conducted in Tororo , a rural district in southeast Uganda , where malaria is holoendemic [ 12 ] .", "label": "", "metadata": {}, "score": "113.61383"}
{"text": "Copyright .\u00a9 Suh et al ; licensee BioMed Central Ltd. 2012 .Current Primary Outcome Measures ICMJE ( submitted : September 20 , 2011 ) .", "label": "", "metadata": {}, "score": "113.80781"}
{"text": "Not Provided .Recruitment Status ICMJE .Active , not recruiting .Enrollment ICMJE .Estimated Completion Date .June 2016 .Primary Completion Date .", "label": "", "metadata": {}, "score": "114.02479"}
{"text": "Nlm Unique ID : 8309603 Medline TA : Clin Nutr Country : - .Other Details : .Languages : ENG Pagination : - Citation Subset : - Experimental Friedreich 's ataxia ( FA ) drug RG2833 , which has been in early - stage development by Massachusetts company Repligen with support from MDA , is now owned by California biotechnology company BioMarin .", "label": "", "metadata": {}, "score": "114.07327"}
{"text": "Volume : - ISSN : 1532 - 1983 ISO Abbreviation : - Publication Date : 2012 Jul .Date Detail : .Created Date : 2012 - 7 - 16 Completed Date : - Revised Date : - .", "label": "", "metadata": {}, "score": "115.7063"}
{"text": "View Article PubMed .Clin Infect Dis 2008 , 46 : 985 - 91 .View Article PubMed .Copyright .\u00a9 Katrak et al .", "label": "", "metadata": {}, "score": "117.64341"}
{"text": "Received : 31 December 2012 / Revised : 5 February 2013 / Accepted : 19 February 2013 / Published : 12 March 2013 .Abstract .", "label": "", "metadata": {}, "score": "119.21896"}
{"text": "Stanislaw Klek ; Cecile Chambrier ; Pierre Singer ; Moshe Rubin ; Tim Bowling ; Michael Staun ; Francisca Joly ; Henrik Rasmussen ; Boyd J Strauss ; Geert Wanten ; Ross Smith ; Arun Abraham ; Kinga Szczepanek ; Jon Shaffer .", "label": "", "metadata": {}, "score": "126.46992"}
{"text": "PubMed .Pre - publication history .Copyright .\u00a9 Berruti et al . ; licensee BioMed Central Ltd. 2014 .This article is published under license to BioMed Central Ltd.", "label": "", "metadata": {}, "score": "128.56631"}
